This is a Validated Antibody Database (VAD) review about human CD38, based on 252 published articles (read how Labome selects the articles), using CD38 antibody in all methods. It is aimed to help Labome visitors find the most suited CD38 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
CD38 synonym: ADPRC 1; ADPRC1

Knockout validation
BD Biosciences
mouse monoclonal (22/CD38)
  • western blot knockout validation; human; loading ...; fig 2d
BD Biosciences CD38 antibody (Becton Dickinson, 611114) was used in western blot knockout validation on human samples (fig 2d). Sci Rep (2017) ncbi
BioLegend
mouse monoclonal (HIT2)
  • flow cytometry; human; loading ...; fig 1c
BioLegend CD38 antibody (BioLegend, 303510) was used in flow cytometry on human samples (fig 1c). Sci Adv (2022) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; loading ...; fig s16
BioLegend CD38 antibody (Biolegend, HIT2) was used in flow cytometry on human samples (fig s16). Mol Ther Methods Clin Dev (2022) ncbi
mouse monoclonal (HIT2)
  • mass cytometry; human; loading ...; fig s4a
BioLegend CD38 antibody (Biolegend, 303535) was used in mass cytometry on human samples (fig s4a). Biomark Res (2022) ncbi
mouse monoclonal (HIT2)
  • other; human; loading ...; fig s3
BioLegend CD38 antibody (Biolegend, HIT2) was used in other on human samples (fig s3). Cancers (Basel) (2021) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; 1:400; loading ...
BioLegend CD38 antibody (BioLegend, 303516) was used in flow cytometry on human samples at 1:400. Cell (2021) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; loading ...
BioLegend CD38 antibody (Biolegend, HIT2) was used in flow cytometry on human samples . Adv Sci (Weinh) (2021) ncbi
mouse monoclonal (HB-7)
  • flow cytometry; human; loading ...; fig 5a
BioLegend CD38 antibody (Biolegend, 356616) was used in flow cytometry on human samples (fig 5a). J Clin Invest (2021) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; loading ...; fig 3b
BioLegend CD38 antibody (Biolegend, HIT2) was used in flow cytometry on human samples (fig 3b). Acta Neuropathol (2021) ncbi
mouse monoclonal (HB-7)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD38 antibody (BioLegend, 356604) was used in flow cytometry on human samples (fig 1a). J Exp Clin Cancer Res (2021) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human
BioLegend CD38 antibody (Biolegend, HIT2) was used in flow cytometry on human samples . Immunity (2021) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; 1:1000; loading ...; fig 1e
BioLegend CD38 antibody (Biolegend, 303509) was used in flow cytometry on human samples at 1:1000 (fig 1e). Cell (2021) ncbi
mouse monoclonal (HB-7)
  • flow cytometry; human; loading ...
BioLegend CD38 antibody (Biolegend, HB7) was used in flow cytometry on human samples . EMBO Mol Med (2021) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; loading ...; fig 3a
BioLegend CD38 antibody (Biolegend, HIT2) was used in flow cytometry on human samples (fig 3a). elife (2020) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; loading ...; fig 4b
BioLegend CD38 antibody (Biolegend, HIT2) was used in flow cytometry on human samples (fig 4b). Cell Death Dis (2020) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; 1:100; loading ...; fig 2s1b
BioLegend CD38 antibody (Biolegend, 303510) was used in flow cytometry on human samples at 1:100 (fig 2s1b). elife (2019) ncbi
mouse monoclonal (HB-7)
  • flow cytometry; human; loading ...; fig 1b
BioLegend CD38 antibody (Biolegend, 356620) was used in flow cytometry on human samples (fig 1b). Cell Mol Gastroenterol Hepatol (2020) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; 1:200; loading ...; fig s10b
BioLegend CD38 antibody (Biolegend, 303524) was used in flow cytometry on human samples at 1:200 (fig s10b). Science (2019) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; loading ...; fig 7b
BioLegend CD38 antibody (BioLegend, HIT2) was used in flow cytometry on human samples (fig 7b). J Immunol (2019) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; fig s5
BioLegend CD38 antibody (BioLegend, HIT2) was used in flow cytometry on human samples (fig s5). Nature (2019) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; 1:40; fig 5b
BioLegend CD38 antibody (Biolegend, 303508) was used in flow cytometry on human samples at 1:40 (fig 5b). Nat Commun (2019) ncbi
mouse monoclonal (HB-7)
  • flow cytometry; human; loading ...; fig 1d
BioLegend CD38 antibody (Biolegend, HB-7) was used in flow cytometry on human samples (fig 1d). Front Immunol (2019) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; loading ...; fig 2a
BioLegend CD38 antibody (BioLegend, 303532) was used in flow cytometry on human samples (fig 2a). Cell (2019) ncbi
mouse monoclonal (HB-7)
  • flow cytometry; human; loading ...; fig 3g
BioLegend CD38 antibody (BioLegend, HB-7) was used in flow cytometry on human samples (fig 3g). Sci Immunol (2019) ncbi
mouse monoclonal (HIT2)
  • mass cytometry; human; loading ...; fig 2b
BioLegend CD38 antibody (Biolegend, 303502) was used in mass cytometry on human samples (fig 2b). Cell (2019) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; loading ...; fig 3a
BioLegend CD38 antibody (Biolegend, HIT2) was used in flow cytometry on human samples (fig 3a). Arthritis Res Ther (2019) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; loading ...; fig s3
BioLegend CD38 antibody (BioLegend, HIT2) was used in flow cytometry on human samples (fig s3). Eur J Immunol (2019) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; loading ...; fig 2b
BioLegend CD38 antibody (Biolegend, 303518) was used in flow cytometry on human samples (fig 2b). Nature (2019) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; fig s1a
BioLegend CD38 antibody (Biolegend, HIT2) was used in flow cytometry on human samples (fig s1a). Cell Stem Cell (2019) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; loading ...; fig s6d
BioLegend CD38 antibody (Biolegend, HIT2) was used in flow cytometry on human samples (fig s6d). Cell (2018) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD38 antibody (Biolegend, 303502) was used in flow cytometry on human samples (fig 1a). Cell (2018) ncbi
mouse monoclonal (HB-7)
  • flow cytometry; human; loading ...; fig s8a
BioLegend CD38 antibody (BioLegend, HB-7) was used in flow cytometry on human samples (fig s8a). Leukemia (2019) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; loading ...; fig s5
BioLegend CD38 antibody (Biolegend, 303532) was used in flow cytometry on human samples (fig s5). J Clin Invest (2018) ncbi
mouse monoclonal (HB-7)
  • flow cytometry; human; fig 7a
BioLegend CD38 antibody (BioLegend, 356618) was used in flow cytometry on human samples (fig 7a). Cell (2018) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; fig s2e
BioLegend CD38 antibody (BioLegend, 303515) was used in flow cytometry on human samples (fig s2e). Cell (2018) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; fig s7g
BioLegend CD38 antibody (BioLegend, 303512) was used in flow cytometry on human samples (fig s7g). Cell (2018) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; loading ...; fig 4a
BioLegend CD38 antibody (Biolegend, HIT2) was used in flow cytometry on human samples (fig 4a). J Immunol (2018) ncbi
mouse monoclonal (HB-7)
  • flow cytometry; human; fig s1a
BioLegend CD38 antibody (Biolegend, HB-7) was used in flow cytometry on human samples (fig s1a). J Cell Sci (2018) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; loading ...; fig 2d
BioLegend CD38 antibody (Biolegend, HIT2) was used in flow cytometry on human samples (fig 2d). J Immunol (2017) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; fig 1b
In order to investigate the role of long-lived plasma cells in immunity and autoimmunity, BioLegend CD38 antibody (BioLegend, HIT2) was used in flow cytometry on human samples (fig 1b). J Immunol (2017) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; loading ...; tbl s3
In order to conduct a phenotypical investigation of clear cell renal cell carcinoma, BioLegend CD38 antibody (biolegend, HIT2) was used in flow cytometry on human samples (tbl s3). Cell (2017) ncbi
mouse monoclonal (HIT2)
  • mass cytometry; human; loading ...; fig s3a
In order to map the lineage of human dendritic cells, BioLegend CD38 antibody (BioLegend, HIT2) was used in mass cytometry on human samples (fig s3a). Science (2017) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; fig 1b
BioLegend CD38 antibody (BioLegend, 303510) was used in flow cytometry on human samples (fig 1b). Scand J Immunol (2017) ncbi
mouse monoclonal (HIT2)
  • mass cytometry; human; fig s8
BioLegend CD38 antibody (BioLegend, 303502) was used in mass cytometry on human samples (fig s8). Nature (2017) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; loading ...; tbl s2
In order to investigate the fecal microbiomes of HIV-uninfected to HIV-infected individuals on long-term antiretroviral therapy, BioLegend CD38 antibody (Biolegend, HIT2) was used in flow cytometry on human samples (tbl s2). Sci Rep (2017) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human
In order to characterize activated T cells in joint tissue from patients with rheumatoid arthritis, BioLegend CD38 antibody (biolegend, HIT-2) was used in flow cytometry on human samples . Nature (2017) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; loading ...; fig 2a
In order to discuss how mutations in PIK3CD and PIK3R1 cause activated PI3K-delta syndrome, BioLegend CD38 antibody (Biolegend, HIT2) was used in flow cytometry on human samples (fig 2a). Clin Immunol (2017) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; mouse; loading ...; fig 2d
In order to study the impact of modulating IFN-I signaling during suppressive combined antiretroviral therapy, BioLegend CD38 antibody (BioLegend, HIT2) was used in flow cytometry on mouse samples (fig 2d). J Clin Invest (2017) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; 1:100; loading ...; fig 1b
In order to explore the role of thrombopoietin signaling in the human primitive hematopoietic stem cell compartment, BioLegend CD38 antibody (BioLegend, HIT2) was used in flow cytometry on human samples at 1:100 (fig 1b). Cell Transplant (2017) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; 1:100; loading ...; fig 1
In order to report the effect of antiretroviral treatment initiation and different antiretroviral treatment regimens on the reconstitution of mucosal T cells within the gut associated lymphoid tissue, BioLegend CD38 antibody (Biolegend, HIT2) was used in flow cytometry on human samples at 1:100 (fig 1). PLoS ONE (2016) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; loading ...; tbl 1
In order to demonstrate that freezing already-stained samples suspended in 10% DMSO in FBS is practical and efficient way to preserve already-stained samples for mass cytometry assessment, BioLegend CD38 antibody (Biolegend, HIT2) was used in flow cytometry on human samples (tbl 1). Cytometry A (2017) ncbi
mouse monoclonal (HB-7)
BioLegend CD38 antibody (Biolegend, 356608) was used . Nat Commun (2016) ncbi
mouse monoclonal (HB-7)
  • flow cytometry; human; loading ...; fig s4
BioLegend CD38 antibody (Biolegend, HB-7) was used in flow cytometry on human samples (fig s4). Nature (2016) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; fig 1
BioLegend CD38 antibody (BioLegend, 303509) was used in flow cytometry on human samples (fig 1). Stem Cell Reports (2016) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; fig 2
In order to evaluate the promotion of B cell activation and CXCR4 downregulation by CD161 and LLT1 expression in human germinal centers, BioLegend CD38 antibody (BioLegend, HIT2) was used in flow cytometry on human samples (fig 2). J Immunol (2016) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; fig s1
In order to describe a highly sensitive microfluidic assay to detect acute myeloid leukemia, BioLegend CD38 antibody (Biolegend, HIT2) was used in flow cytometry on human samples (fig s1). Analyst (2016) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; loading ...; fig 2a
In order to study age-related changes in human immunity during a primary virus infection experimentally induced by immunization with live-attenuated yellow fever vaccine, BioLegend CD38 antibody (Biolegend, HIT2) was used in flow cytometry on human samples (fig 2a). J Immunol (2015) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; fig 1
In order to assess the CD4/CD8 ratio as a marker for CD4+ T cell dysfunction in chronic HIV infection, BioLegend CD38 antibody (Biolegend, clone HIT2) was used in flow cytometry on human samples (fig 1). PLoS ONE (2015) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; fig  4
BioLegend CD38 antibody (Biolegend, HIT2) was used in flow cytometry on human samples (fig  4). Cancer Immunol Immunother (2015) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; fig 3
BioLegend CD38 antibody (BIOLEGEND, HIT2) was used in flow cytometry on human samples (fig 3). PLoS ONE (2015) ncbi
mouse monoclonal (HIT2)
  • immunocytochemistry; human; fig 1
BioLegend CD38 antibody (BioLegend, 303509) was used in immunocytochemistry on human samples (fig 1). Leukemia (2015) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; 1:80
In order to develop a system to determine human DC development and differentiation, BioLegend CD38 antibody (Biolegend, HIT2) was used in flow cytometry on human samples at 1:80. J Immunol Methods (2015) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; fig 5
BioLegend CD38 antibody (BioLegend, HIT2) was used in flow cytometry on human samples (fig 5). J Exp Med (2015) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; fig 5
BioLegend CD38 antibody (Biolegend, # 303515) was used in flow cytometry on human samples (fig 5). Biomaterials (2015) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; tbl s1
BioLegend CD38 antibody (Biolegend, HIT2) was used in flow cytometry on human samples (tbl s1). PLoS ONE (2015) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; fig 1
BioLegend CD38 antibody (Biolegend, HIT2) was used in flow cytometry on human samples (fig 1). Int Immunol (2015) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; fig 3
BioLegend CD38 antibody (BioLegend, HIT2) was used in flow cytometry on human samples (fig 3). J Autoimmun (2015) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; fig 4
BioLegend CD38 antibody (Biolegend, HIT2) was used in flow cytometry on human samples (fig 4). Cytokine (2015) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; fig 4
BioLegend CD38 antibody (BioLegend, HIT2) was used in flow cytometry on human samples (fig 4). Immunol Cell Biol (2015) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human
In order to identify the role of GammaDelta T cells in acute HIV infection, BioLegend CD38 antibody (Biolegend, HIT2) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human
BioLegend CD38 antibody (Biolegend, HIT2) was used in flow cytometry on human samples . Ann Rheum Dis (2015) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; fig 1
In order to study the role of plasmacytoid dendritic cells in human immunodeficiency virus type 1 infection and pathogenesis, BioLegend CD38 antibody (Biolegend, 303506) was used in flow cytometry on human samples (fig 1). PLoS Pathog (2014) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human
BioLegend CD38 antibody (BioLegend, HIT-2) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human
BioLegend CD38 antibody (BioLegend, HIT2) was used in flow cytometry on human samples . Blood (2014) ncbi
Invitrogen
mouse monoclonal (HIT2)
  • flow cytometry; human; loading ...; fig 5g
Invitrogen CD38 antibody (eBioscience, 12-0389-42) was used in flow cytometry on human samples (fig 5g). Sci Transl Med (2022) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; mouse; fig 1e-h
Invitrogen CD38 antibody (eBioscience, HIT2) was used in flow cytometry on mouse samples (fig 1e-h). Adv Sci (Weinh) (2021) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; fig 5b
Invitrogen CD38 antibody (Thermo Fisher Scientific, HIT2) was used in flow cytometry on human samples (fig 5b). ACS Synth Biol (2021) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; loading ...; fig 1a
Invitrogen CD38 antibody (eBioscience, 17-0389-42) was used in flow cytometry on human samples (fig 1a). J Exp Med (2019) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; 1:1200; loading ...; fig 1a
Invitrogen CD38 antibody (eBioscience, 25-0389-42) was used in flow cytometry on human samples at 1:1200 (fig 1a). elife (2019) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; loading ...; fig 2a
Invitrogen CD38 antibody (Thermo Fisher Scientific, 25-0389-42) was used in flow cytometry on human samples (fig 2a). Sci Rep (2019) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; loading ...; fig 1a
Invitrogen CD38 antibody (eBioscience, HIT2) was used in flow cytometry on human samples (fig 1a). Front Immunol (2018) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; loading ...; fig 4a
Invitrogen CD38 antibody (Thermo Fisher, HIT2) was used in flow cytometry on human samples (fig 4a). J Clin Invest (2018) ncbi
mouse monoclonal (HB7)
  • flow cytometry; human; 1:50; loading ...; fig 7a
Invitrogen CD38 antibody (eBioscience, 85-25-0388-41) was used in flow cytometry on human samples at 1:50 (fig 7a). J Clin Invest (2018) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; loading ...
In order to show T cell immunoglobulin and ITIM domain expression increases over time despite early initiation of antiretroviral treatment, Invitrogen CD38 antibody (eBioscience, HIT2) was used in flow cytometry on human samples . Sci Rep (2017) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; loading ...; fig 1a
In order to study the restoration of immune function in chronic HIV infection, Invitrogen CD38 antibody (eBioscience, HIT2) was used in flow cytometry on human samples (fig 1a). J Clin Invest (2017) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; loading ...; fig 1a
In order to investigate how differences in B cell populations may contribute to HIV susceptibility, Invitrogen CD38 antibody (Invitrogen, HIT2) was used in flow cytometry on human samples (fig 1a). AIDS Res Hum Retroviruses (2016) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; loading ...; fig 2a
In order to characterize B cells and antibody repertoires from injection drug users, Invitrogen CD38 antibody (Invitrogen, HIT2) was used in flow cytometry on human samples (fig 2a). PLoS ONE (2016) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; loading ...; fig 2a
In order to develop a method to detect circulating B cells that recognize nuclear antigens in patients, Invitrogen CD38 antibody (Invitrogen, HIT2) was used in flow cytometry on human samples (fig 2a). Arthritis Rheumatol (2016) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; 1:100; fig 8
Invitrogen CD38 antibody (eBioscience, 17-0389) was used in flow cytometry on human samples at 1:100 (fig 8). Haematologica (2016) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; loading ...; fig 1c
In order to characterize B and T cells from patients with thrombocytopenia, Invitrogen CD38 antibody (eBioscience, 25-0389) was used in flow cytometry on human samples (fig 1c). Haematologica (2016) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; loading ...; tbl s1
In order to explore how junctional adhesion molecule family members differentially regulate CXCR4 function and CXCL12 secretion in the bone marrow niche, Invitrogen CD38 antibody (ThermoFisher, MHCD3817) was used in flow cytometry on human samples (tbl s1). Stem Cells (2016) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; loading ...; fig 1c
Invitrogen CD38 antibody (eBioscience, HIT2) was used in flow cytometry on human samples (fig 1c). PLoS Pathog (2016) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; loading ...; fig 1
In order to characterize the gut-associated lymphoid tissue of HIV-controllers, Invitrogen CD38 antibody (eBioscience, HIT2) was used in flow cytometry on human samples (fig 1). Immunol Res (2016) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; mouse; loading ...; fig 4j
In order to assess the effects of allosteric inhibitors on different mutant forms of isocitrate dehydrogenase 1 in leukemia, Invitrogen CD38 antibody (eBioscience, HIT2) was used in flow cytometry on mouse samples (fig 4j). Nat Chem Biol (2015) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human
In order to elucidate regulation of gamma-globin expression in F-cells, Invitrogen CD38 antibody (e-bioscience, HIT-2) was used in flow cytometry on human samples . PLoS ONE (2015) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; fig 2
In order to examine the role of lymphocyte activation gene-3 during HIV infection, Invitrogen CD38 antibody (eBioscience, HIT2) was used in flow cytometry on human samples (fig 2). J Immunol (2015) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; fig 4
Invitrogen CD38 antibody (eBioscience, HIT2) was used in flow cytometry on human samples (fig 4). J Immunol (2015) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human
Invitrogen CD38 antibody (eBioscience, HIT2) was used in flow cytometry on human samples . J Allergy Clin Immunol (2015) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; 1:50
Invitrogen CD38 antibody (eBioscience, HIT2) was used in flow cytometry on human samples at 1:50. Nat Med (2014) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human
Invitrogen CD38 antibody (eBioscience, HIT2) was used in flow cytometry on human samples . J Infect Dis (2014) ncbi
mouse monoclonal (38C03 (SPC32))
  • immunohistochemistry - paraffin section; human
In order to describe the features of plasma cells in patients with granulomatosis with polyangiitis, Invitrogen CD38 antibody (Labvision, 38C03) was used in immunohistochemistry - paraffin section on human samples . Arthritis Res Ther (2014) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human
In order to use Dasatinib to identify targetable metabolic differences in primary chronic lymphocytic leukemia lymphocytes, Invitrogen CD38 antibody (Invitrogen, MHCD3805) was used in flow cytometry on human samples . Oncotarget (2013) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human
Invitrogen CD38 antibody (eBioscience, HIT2) was used in flow cytometry on human samples . Immunology (2014) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human
Invitrogen CD38 antibody (eBioscience, HIT2) was used in flow cytometry on human samples . J Hepatol (2014) ncbi
mouse monoclonal (38C03 (SPC32))
  • immunohistochemistry - paraffin section; human; 1:50; tbl 2
In order to discuss how Epstein-Barr virus contributes to the development of small B-cell neoplasms, Invitrogen CD38 antibody (Neomarkers, 38C03) was used in immunohistochemistry - paraffin section on human samples at 1:50 (tbl 2). PLoS ONE (2012) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; fig 4
In order to investigate the CSK polymorphism rs34933034 in B cells and lupus, Invitrogen CD38 antibody (Invitrogen, MHCD3817) was used in flow cytometry on human samples (fig 4). Nat Genet (2012) ncbi
mouse monoclonal (AT13/5)
  • immunohistochemistry - paraffin section; human
In order to determine the clinicopathologic features and diagnosis of extraosseous plasmacytomas, Invitrogen CD38 antibody (NeoMarker, AT1) was used in immunohistochemistry - paraffin section on human samples . Diagn Pathol (2011) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; fig 1d
In order to develop a xenotransplantation system using human hematopoietic stem cells and mice, Invitrogen CD38 antibody (Caltag, HIT2) was used in flow cytometry on human samples (fig 1d). Nat Protoc (2008) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; fig 3
In order to identify changes in peripheral B cell subsets in patients with systemic lupus erythematosus, Invitrogen CD38 antibody (Invitrogen, HIT2) was used in flow cytometry on human samples (fig 3). Arthritis Rheum (2008) ncbi
mouse monoclonal (HB7)
  • flow cytometry; human
In order to test if the humoral immunity specific for the chronic lymphocytic leukemia-associated Ag oncofetal Ag/immature laminin receptor has a prognostic value in chronic lymphocytic leukemia, Invitrogen CD38 antibody (Caltag Laboratories, HB-7) was used in flow cytometry on human samples . J Immunol (2008) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human
In order to characterize CD34+ cells from bone marrow of untreated patients with chronic myelogenous leukemia in chronic phase, Invitrogen CD38 antibody (Caltag, HIT2) was used in flow cytometry on human samples . Leukemia (2007) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; fig 1
In order to characterize B cells in human tonsils, Invitrogen CD38 antibody (Caltag, HIT 2) was used in flow cytometry on human samples (fig 1). Blood (2007) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human
In order to study how the human VH4 immunoglobulin repertoire changes with age, Invitrogen CD38 antibody (Caltag, HIT 2) was used in flow cytometry on human samples . Scand J Immunol (2006) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; fig 3
In order to assess the use of CD33-related siglecs as markers of acute myeloid leukemia, Invitrogen CD38 antibody (Caltag-Medsystems, HIT2) was used in flow cytometry on human samples (fig 3). Leuk Res (2007) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human
In order to detect the JAK2 V617F mutation in hematopoietic stem cells and their progeny in patients with polycythemia vera, Invitrogen CD38 antibody (Caltag, HIT2) was used in flow cytometry on human samples . Proc Natl Acad Sci U S A (2006) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; tbl 1
In order to assess the capacity of cord blood stem cells to repopulate irradiated NOD/SCID mice after cryopreservation, Invitrogen CD38 antibody (Caltag, HIT 2) was used in flow cytometry on human samples (tbl 1). Haematologica (2006) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; fig 1A
In order to discuss the roles of thrombopoietin and c-mpl in hematopoiesis, Invitrogen CD38 antibody (Caltag, HIT2) was used in flow cytometry on human samples (fig 1A). J Transl Med (2006) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human
In order to show that T cell expansion and contractions in persistent viral infections is not limited to the acute phase of infection, but continues in latent infection, Invitrogen CD38 antibody (Caltag, HIT2) was used in flow cytometry on human samples . Eur J Immunol (2005) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human
In order to study the use of plasma cells for transplantation, Invitrogen CD38 antibody (Caltag, MHCD3801) was used in flow cytometry on human samples . Haematologica (2003) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human
In order to report that Varicella-zoster virus infects human tonsillar CD4(+) T cells, Invitrogen CD38 antibody (Caltag, HIT-2) was used in flow cytometry on human samples . J Virol (2002) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; fig 2
In order to measure interleukin-10 and transforming growth factor-beta1 produced by T cells from healthy volunteer donors treated with recombinant human G-CSF, Invitrogen CD38 antibody (Caltag Laboratories, clone HIT2) was used in flow cytometry on human samples (fig 2). Blood (2002) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human
In order to report how to isolate highly purified hematopoietic intermediates, Invitrogen CD38 antibody (Caltag, HIT2) was used in flow cytometry on human samples . Proc Natl Acad Sci U S A (2002) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; fig 2
In order to test if phosphoinositide 3-kinase is involved in the modification of CD38 antigen expression on myeloid cells, Invitrogen CD38 antibody (Caltag, Clone HIT2) was used in flow cytometry on human samples (fig 2). Br J Haematol (2002) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; fig 1
In order to elucidate the molecular processes that maintain the stem cell pool, Invitrogen CD38 antibody (Caltag, HIT2) was used in flow cytometry on human samples (fig 1). Exp Hematol (2000) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human
In order to assess the repopulating potential of transduced grafts, Invitrogen CD38 antibody (Caltag, HIT2) was used in flow cytometry on human samples . Blood (2000) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human
In order to report that the expression of CD41 and c-mpl were not predictive of commitment to the megakaryocyte lineage, Invitrogen CD38 antibody (Caltag, HIT2) was used in flow cytometry on human samples . Br J Haematol (1999) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; fig 4
In order to investigate the expression and function of B cell CD154, Invitrogen CD38 antibody (Caltag, HIT2) was used in flow cytometry on human samples (fig 4). J Immunol (1999) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human
In order to characterize CD34+ cells derived from human cord blood after culture, Invitrogen CD38 antibody (Caltag, HIT2) was used in flow cytometry on human samples . Br J Haematol (1999) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human
In order to study the origin of peripheral blood B cells in patients with MM, Invitrogen CD38 antibody (Caltag, HIT2) was used in flow cytometry on human samples . Clin Exp Immunol (1998) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; fig 5
In order to determine the effects of delta-aminolevulinic acid and delta-aminolevulinic acid-photodynamic therapy on resting and activated human peripheral blood T lymphocytes, Invitrogen CD38 antibody (Caltag, HIT2) was used in flow cytometry on human samples (fig 5). Photochem Photobiol (1998) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human
In order to elucidate factors that could prompt early peripheral blood recovery after cord blood transplantation, Invitrogen CD38 antibody (Caltag, HIT2) was used in flow cytometry on human samples . Bone Marrow Transplant (1998) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; fig 3
In order to identify c-met-encoded receptor tyrosine kinase and its ligand, HGF/SF, as a novel paracrine signaling pathway that regulates B cell adhesion, Invitrogen CD38 antibody (Caltag, HIT2) was used in flow cytometry on human samples (fig 3). J Exp Med (1997) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human
In order to assess the effects of the FLK-2/FLT-3 ligand on the growth of human fetal liver progenitors, Invitrogen CD38 antibody (Caltag, HIT2) was used in flow cytometry on human samples . Blood (1995) ncbi
Santa Cruz Biotechnology
mouse monoclonal (H-11)
  • immunohistochemistry - frozen section; rat; 1:25; loading ...; fig 3a
  • western blot; rat; 1:100; loading ...; fig 2c
Santa Cruz Biotechnology CD38 antibody (Santa Cruz, sc-374650) was used in immunohistochemistry - frozen section on rat samples at 1:25 (fig 3a) and in western blot on rat samples at 1:100 (fig 2c). Front Pharmacol (2022) ncbi
R&D Systems
mouse monoclonal (240742)
  • flow cytometry; human; 1:200; fig 4f
R&D Systems CD38 antibody (R&D Systems, FAB2404P) was used in flow cytometry on human samples at 1:200 (fig 4f). Nat Neurosci (2022) ncbi
Abcam
domestic rabbit monoclonal (EPR4106)
  • immunohistochemistry - paraffin section; human; tbl s7
In order to conduct a phenotypical investigation of clear cell renal cell carcinoma, Abcam CD38 antibody (Abcam, EPR4106) was used in immunohistochemistry - paraffin section on human samples (tbl s7). Cell (2017) ncbi
mouse monoclonal (FS02)
  • western blot; mouse; 1:1000; loading ...; fig 5e
Abcam CD38 antibody (Abcam, ab1173) was used in western blot on mouse samples at 1:1000 (fig 5e). Mol Biol Cell (2016) ncbi
domestic rabbit monoclonal (EPR4106)
  • immunocytochemistry; human; 1:100; fig 3
Abcam CD38 antibody (Abcam, ab108403) was used in immunocytochemistry on human samples at 1:100 (fig 3). Lab Chip (2015) ncbi
Miltenyi Biotec
human monoclonal (REA572)
  • flow cytometry; human; fig 3d
Miltenyi Biotec CD38 antibody (Miltenyi Biotec, REA572) was used in flow cytometry on human samples (fig 3d). N Biotechnol (2018) ncbi
mouse monoclonal (IB6)
  • flow cytometry; human; loading ...; fig 4c
Miltenyi Biotec CD38 antibody (Miltenyi Biotec, IB6) was used in flow cytometry on human samples (fig 4c). Int J Mol Sci (2017) ncbi
Beckman Coulter
mouse monoclonal (LS198-4-3)
  • flow cytometry; human; 1:20; loading ...; fig 2
Beckman Coulter CD38 antibody (Beckman Coulter, LS198-4-3) was used in flow cytometry on human samples at 1:20 (fig 2). elife (2020) ncbi
mouse monoclonal (T16)
  • flow cytometry; human; fig 1b
In order to explore the contribution of CD105 to leukemogenesis, Beckman Coulter CD38 antibody (Beckman Coulter, T16) was used in flow cytometry on human samples (fig 1b). Blood (2017) ncbi
mouse monoclonal (LS198-4-3)
  • flow cytometry; human; loading ...; fig 2a
In order to discuss how mutations in PIK3CD and PIK3R1 cause activated PI3K-delta syndrome, Beckman Coulter CD38 antibody (Beckman Coulter, LS198-4-3) was used in flow cytometry on human samples (fig 2a). Clin Immunol (2017) ncbi
mouse monoclonal (LS198-4-3)
  • flow cytometry; human; 1:25; fig 2
Beckman Coulter CD38 antibody (Beckman Coulter, LS198-4-3) was used in flow cytometry on human samples at 1:25 (fig 2). Nat Commun (2016) ncbi
mouse monoclonal (T16)
  • other; human; 200 ug/ml; fig 3
Beckman Coulter CD38 antibody (Beckman Coulter, IM0366) was used in other on human samples at 200 ug/ml (fig 3). J Extracell Vesicles (2016) ncbi
mouse monoclonal (T16)
  • flow cytometry; human; tbl 4
In order to discuss how to diagnosis hematolymphoid neoplasms using flow cytometry, Beckman Coulter CD38 antibody (Beckman Coulter, T16) was used in flow cytometry on human samples (tbl 4). Cytometry B Clin Cytom (2015) ncbi
mouse monoclonal (LS198-4-3)
  • flow cytometry; human
Beckman Coulter CD38 antibody (Beckman-Coulter, LS198-4-3) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
Stemcell Technologies
mouse monoclonal (AT-1)
  • flow cytometry; African green monkey; loading ...; fig 5c
Stemcell Technologies CD38 antibody (Stem Cell, 60131FI) was used in flow cytometry on African green monkey samples (fig 5c). PLoS Pathog (2020) ncbi
mouse monoclonal (AT-1)
  • flow cytometry; rhesus macaque; 1:200; loading ...; fig 3g
Stemcell Technologies CD38 antibody (Stem Cell technologies, 60131FI) was used in flow cytometry on rhesus macaque samples at 1:200 (fig 3g). Nature (2019) ncbi
Cytognos
monoclonal (LD38)
  • flow cytometry; human; loading ...; tbl 1
In order to compare the use of CD229, CD54, and CD319 expression for the identification of normal and aberrant plasma cells, Cytognos CD38 antibody (Cytognos, LD38) was used in flow cytometry on human samples (tbl 1). Cytometry B Clin Cytom (2016) ncbi
BD Biosciences
mouse monoclonal (HIT2)
  • flow cytometry; human; loading ...; fig 2i, s6g
BD Biosciences CD38 antibody (BD Biosciences, HIT2) was used in flow cytometry on human samples (fig 2i, s6g). Nat Commun (2022) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; mouse; loading ...; fig e5b
BD Biosciences CD38 antibody (BD Pharmingen, HIT2) was used in flow cytometry on mouse samples (fig e5b). Nature (2022) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; fig s5l
BD Biosciences CD38 antibody (BD Bioscience, 560981) was used in flow cytometry on human samples (fig s5l). J Exp Med (2022) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; loading ...
BD Biosciences CD38 antibody (BD Pharmingen, 551400) was used in flow cytometry on human samples . Signal Transduct Target Ther (2021) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; 1:400; loading ...; fig s2c
BD Biosciences CD38 antibody (BD Biosciences, HIT2) was used in flow cytometry on human samples at 1:400 (fig s2c). Nature (2021) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; loading ...; fig s3
BD Biosciences CD38 antibody (BD, HIT2) was used in flow cytometry on human samples (fig s3). Cancers (Basel) (2021) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; 1:500; loading ...; fig 3c
BD Biosciences CD38 antibody (BD Horizon, HIT2) was used in flow cytometry on human samples at 1:500 (fig 3c). Nature (2021) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; 1:200; loading ...; fig s1h
BD Biosciences CD38 antibody (BD Biosciences, HIT2) was used in flow cytometry on human samples at 1:200 (fig s1h). Nature (2021) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; loading ...; fig 5a
BD Biosciences CD38 antibody (BD Biosciences, 551400) was used in flow cytometry on human samples (fig 5a). elife (2020) ncbi
mouse monoclonal (HB7)
  • flow cytometry; human; loading ...
BD Biosciences CD38 antibody (BD Biosciences, 335790) was used in flow cytometry on human samples . J Clin Invest (2020) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; loading ...
BD Biosciences CD38 antibody (BD Biosciences, 560982) was used in flow cytometry on human samples . J Clin Invest (2020) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; loading ...; fig 2a
BD Biosciences CD38 antibody (BD Biosciences, HIT2) was used in flow cytometry on human samples (fig 2a). Science (2020) ncbi
mouse monoclonal (HIT2)
  • mass cytometry; human; 500 ug/ml; loading ...; fig s11a
BD Biosciences CD38 antibody (BD, HIT2) was used in mass cytometry on human samples at 500 ug/ml (fig s11a). Nature (2020) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; loading ...; fig s10b
BD Biosciences CD38 antibody (BD Biosciences, 555462) was used in flow cytometry on human samples (fig s10b). Nat Commun (2019) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; loading ...; fig 1b
BD Biosciences CD38 antibody (BD Pharmingen, 560982) was used in flow cytometry on human samples (fig 1b). Sci Rep (2019) ncbi
mouse monoclonal (HB7)
  • flow cytometry; human; 1:10; loading ...; fig 2f
BD Biosciences CD38 antibody (BD, 347687) was used in flow cytometry on human samples at 1:10 (fig 2f). Nature (2019) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; loading ...; fig s7b
BD Biosciences CD38 antibody (BD Biosciences, 555462) was used in flow cytometry on human samples (fig s7b). Mol Cell (2019) ncbi
mouse monoclonal (HB7)
  • flow cytometry; human; loading ...; fig s1b
BD Biosciences CD38 antibody (BD Biosciences, 347687) was used in flow cytometry on human samples (fig s1b). Cell (2019) ncbi
mouse monoclonal (HB7)
  • flow cytometry; human; loading ...; fig 1a
BD Biosciences CD38 antibody (BD Biosciences, HB7) was used in flow cytometry on human samples (fig 1a). Blood Cancer J (2019) ncbi
mouse monoclonal (HB7)
  • flow cytometry; human; 1:50; loading ...; fig 4b
BD Biosciences CD38 antibody (BD Biosciences, HB7) was used in flow cytometry on human samples at 1:50 (fig 4b). Nat Commun (2019) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; loading ...; fig 3a
BD Biosciences CD38 antibody (BD Horizon, HIT2) was used in flow cytometry on human samples (fig 3a). J Clin Invest (2019) ncbi
mouse monoclonal (HB7)
  • flow cytometry; human; loading ...; fig 2c
BD Biosciences CD38 antibody (BD Biosciences, HB7) was used in flow cytometry on human samples (fig 2c). Sci Rep (2018) ncbi
mouse monoclonal (HB7)
  • flow cytometry; mouse; loading ...; fig 3c
BD Biosciences CD38 antibody (BD Biosciences, HB7) was used in flow cytometry on mouse samples (fig 3c). Sci Rep (2018) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; loading ...; fig 1a
BD Biosciences CD38 antibody (BD Biosciences, 555462) was used in flow cytometry on human samples (fig 1a). J Clin Invest (2018) ncbi
mouse monoclonal (HB7)
BD Biosciences CD38 antibody (BD Biosciences, HB7) was used . Cell Stem Cell (2018) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; loading ...; fig 2a
BD Biosciences CD38 antibody (BD Biosciences, 555460) was used in flow cytometry on human samples (fig 2a). J Virol (2018) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; loading ...; fig 1a
BD Biosciences CD38 antibody (BD Biosciences, 562445) was used in flow cytometry on human samples (fig 1a). Front Immunol (2018) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; loading ...; fig s7j
BD Biosciences CD38 antibody (BD, 555462) was used in flow cytometry on human samples (fig s7j). Nat Med (2018) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; loading ...; fig 3a
BD Biosciences CD38 antibody (Becton Dickinson, 555460) was used in flow cytometry on human samples (fig 3a). Sci Rep (2017) ncbi
mouse monoclonal (22/CD38)
  • western blot knockout validation; human; loading ...; fig 2d
BD Biosciences CD38 antibody (Becton Dickinson, 611114) was used in western blot knockout validation on human samples (fig 2d). Sci Rep (2017) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; 1:10; fig s2
BD Biosciences CD38 antibody (BD, HIT2) was used in flow cytometry on human samples at 1:10 (fig s2). Nat Commun (2017) ncbi
mouse monoclonal (HB7)
  • flow cytometry; human; fig 3d
In order to investigate the role of dopamine in B cell maturation in germinal centres, BD Biosciences CD38 antibody (BD Biosciences, HB7) was used in flow cytometry on human samples (fig 3d). Nature (2017) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; fig 3d
In order to investigate the role of dopamine in B cell maturation in germinal centres, BD Biosciences CD38 antibody (BD Biosciences, HIT2) was used in flow cytometry on human samples (fig 3d). Nature (2017) ncbi
mouse monoclonal (HIT2)
  • other; human; loading ...; fig s1
  • ELISA; human; fig st2
In order to investigate the mechanisms of toxicity by the negative allosteric modulators of metabotropic glutamate receptor 5, BD Biosciences CD38 antibody (BD/Pharm, 555458) was used in other on human samples (fig s1) and in ELISA on human samples (fig st2). Cell Chem Biol (2017) ncbi
mouse monoclonal (HB7)
  • flow cytometry; human; loading ...; fig s2
BD Biosciences CD38 antibody (BD Pharmingen, 335808) was used in flow cytometry on human samples (fig s2). Scand J Immunol (2017) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; loading ...; tbl s9
In order to optimize and assess potential malaria vaccine regimens, BD Biosciences CD38 antibody (BD, 555461) was used in flow cytometry on human samples (tbl s9). Nature (2017) ncbi
mouse monoclonal (HB7)
  • flow cytometry; human; loading ...
BD Biosciences CD38 antibody (Pharmingen, HB7) was used in flow cytometry on human samples . Oncol Lett (2017) ncbi
mouse monoclonal (HB7)
  • flow cytometry; human; loading ...; fig 2a
In order to discuss how mutations in PIK3CD and PIK3R1 cause activated PI3K-delta syndrome, BD Biosciences CD38 antibody (BD Biosciences, HB7) was used in flow cytometry on human samples (fig 2a). Clin Immunol (2017) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; loading ...
In order to show T cell immunoglobulin and ITIM domain expression increases over time despite early initiation of antiretroviral treatment, BD Biosciences CD38 antibody (BD Bioscience, HIT2) was used in flow cytometry on human samples . Sci Rep (2017) ncbi
mouse monoclonal (HB7)
  • flow cytometry; human; fig 4a
In order to propose that decidual stromal cells are a cellular source of BAFF for B cells present in decidua during pregnancy, BD Biosciences CD38 antibody (BD Bioscience, 345806) was used in flow cytometry on human samples (fig 4a). Sci Rep (2017) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; fig 2c
BD Biosciences CD38 antibody (BD Biosciences, HIT2) was used in flow cytometry on human samples (fig 2c). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (HB7)
  • flow cytometry; human; tbl 3
In order to document and describe lymphocyte predominant cells from lymph nodes involved in nodular lymphocyte predominant Hodgkin lymphoma, BD Biosciences CD38 antibody (BD Biosciences, HB7) was used in flow cytometry on human samples (tbl 3). Am J Pathol (2017) ncbi
mouse monoclonal (HB7)
  • flow cytometry; human; 1:200; fig s1c
BD Biosciences CD38 antibody (BD, 335790) was used in flow cytometry on human samples at 1:200 (fig s1c). Nature (2016) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; loading ...; fig s12b
BD Biosciences CD38 antibody (BD Biosciences, HIT2) was used in flow cytometry on human samples (fig s12b). J Clin Invest (2016) ncbi
mouse monoclonal (HB7)
  • flow cytometry; human; fig e7a
In order to report preclinical studies using a CRISPR-based methodology to target hematopoietic stem cells to treat beta-haemoglobinopathies, BD Biosciences CD38 antibody (BD Biosciences, HB7) was used in flow cytometry on human samples (fig e7a). Nature (2016) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; loading ...; tbl 3
BD Biosciences CD38 antibody (BD Pharmingen, HIT2) was used in flow cytometry on human samples (tbl 3). Brain Behav (2016) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; loading ...; fig 3c
BD Biosciences CD38 antibody (BD Biosciences, HIT2) was used in flow cytometry on human samples (fig 3c). J Biol Chem (2016) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; loading ...; fig 4a
In order to characterize CD8 positive T cell subsets in dengue patients from India and Thailand, BD Biosciences CD38 antibody (BD, 562288) was used in flow cytometry on human samples (fig 4a). J Virol (2016) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; loading ...; fig 1a, s4
In order to discuss targeting CD123 to treat systemic lupus erythematosus, BD Biosciences CD38 antibody (BD Biosciences, 562444) was used in flow cytometry on human samples (fig 1a, s4). JCI Insight (2016) ncbi
mouse monoclonal (HB7)
  • flow cytometry; human; loading ...; fig 1a, s4
In order to discuss targeting CD123 to treat systemic lupus erythematosus, BD Biosciences CD38 antibody (BD Biosciences, 335790) was used in flow cytometry on human samples (fig 1a, s4). JCI Insight (2016) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; loading ...; fig st1
BD Biosciences CD38 antibody (BD Biosciences, 551400) was used in flow cytometry on human samples (fig st1). PLoS ONE (2016) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; 1:50; loading ...
In order to find that leukocyte cell-derived chemotaxin 2 promotes expansion and mobilization of hematopoietic stem cells, BD Biosciences CD38 antibody (BD Biosciences, HIT2) was used in flow cytometry on human samples at 1:50. Nat Commun (2016) ncbi
mouse monoclonal (HB7)
  • flow cytometry; human; loading ...; fig st9
In order to characterize American patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy, BD Biosciences CD38 antibody (BD Biosciences, HB7) was used in flow cytometry on human samples (fig st9). JCI Insight (2016) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; loading ...; fig 1a
BD Biosciences CD38 antibody (Becton Dickinson, HIT2) was used in flow cytometry on human samples (fig 1a). PLoS ONE (2016) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; loading ...; fig 4a
In order to report that IgA-producing plasma cells are a major source of inducible NO synthase in Helicobacter pylori-infected patients, BD Biosciences CD38 antibody (BD, HIT2) was used in flow cytometry on human samples (fig 4a). J Immunol (2016) ncbi
mouse monoclonal (HB7)
  • flow cytometry; human; loading ...
BD Biosciences CD38 antibody (BD Biosciences, 340926) was used in flow cytometry on human samples . Oncol Lett (2016) ncbi
mouse monoclonal (HB7)
  • flow cytometry; human; loading ...; fig 3a
In order to study the function of desmoglein-2 and generate knockout mice, BD Biosciences CD38 antibody (BD, HB7) was used in flow cytometry on human samples (fig 3a). Angiogenesis (2016) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; 1:50; fig 1
BD Biosciences CD38 antibody (BD, 555462) was used in flow cytometry on human samples at 1:50 (fig 1). Nat Commun (2016) ncbi
mouse monoclonal (HB7)
  • flow cytometry; human; fig s2
BD Biosciences CD38 antibody (BD Biosciences, HB7) was used in flow cytometry on human samples (fig s2). Sci Rep (2016) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; fig 1
BD Biosciences CD38 antibody (Becton Dickinson, 551400) was used in flow cytometry on human samples (fig 1). Blood (2016) ncbi
mouse monoclonal (HB7)
  • flow cytometry; human; 1:50; loading ...; fig 5f
In order to develop and characterize a humanized ossicle xenotransplantation approach, BD Biosciences CD38 antibody (BD, HB7) was used in flow cytometry on human samples at 1:50 (fig 5f). Nat Med (2016) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; 1:100; loading ...; fig 1b
In order to study how retinoic acid-induced HOXA gene expression controls hematopoietic stem/progenitor cells fate, identify, and function, BD Biosciences CD38 antibody (BD, 560677) was used in flow cytometry on human samples at 1:100 (fig 1b). Nat Cell Biol (2016) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; fig 1
  • immunocytochemistry; human; fig 4
BD Biosciences CD38 antibody (BD, HIT-2) was used in flow cytometry on human samples (fig 1) and in immunocytochemistry on human samples (fig 4). JCI Insight (2016) ncbi
mouse monoclonal (HB7)
  • flow cytometry; human; fig e1c
In order to explore the contribution of Musashi-2 in determining hematopoietic stem cell fate, BD Biosciences CD38 antibody (BD biosciences, HB7) was used in flow cytometry on human samples (fig e1c). Nature (2016) ncbi
mouse monoclonal (HB7)
  • flow cytometry; human; loading ...; fig 1b
BD Biosciences CD38 antibody (BD, HB7) was used in flow cytometry on human samples (fig 1b). Cancer Med (2016) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; loading ...; fig s2
In order to discover that T follicular helper cells preferentially express the transcriptional coactivator Bob1, BD Biosciences CD38 antibody (BD Biosciences, HIT2) was used in flow cytometry on human samples (fig s2). Eur J Immunol (2016) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; loading ...; fig s2d
BD Biosciences CD38 antibody (BD Biosciences, HIT2) was used in flow cytometry on human samples (fig s2d). J Immunol (2016) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; fig 9a
In order to identify a B cell-intrinsic mechanism by which IFN signaling promotes lupus pathogenesis, BD Biosciences CD38 antibody (BD, HIT2) was used in flow cytometry on human samples (fig 9a). J Exp Med (2016) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; fig s4
In order to assess the effects of lenalidomide on normal human plasma cell generation, BD Biosciences CD38 antibody (BD Biosciences, HIT2) was used in flow cytometry on human samples (fig s4). Oncotarget (2016) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; baboons; fig 5
In order to analyze how chimeric 2C10R4 anti-CD40 antibody therapy is essential for long-term survival of pig-to-primate cardiac xenograft (GTKO.hCD46.hTBM), BD Biosciences CD38 antibody (Pharmingen, 561106) was used in flow cytometry on baboons samples (fig 5). Nat Commun (2016) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; mouse; fig 7d
  • flow cytometry; human; loading ...; fig 7c
BD Biosciences CD38 antibody (BD Biosciences, 562444) was used in flow cytometry on mouse samples (fig 7d) and in flow cytometry on human samples (fig 7c). J Biol Chem (2016) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; 1:20; fig 1
BD Biosciences CD38 antibody (BD Pharmingen, 555461) was used in flow cytometry on human samples at 1:20 (fig 1). Mol Med Rep (2016) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; fig st1
In order to find cell-surface markers specific to human neutrophils, BD Biosciences CD38 antibody (BD, 555460) was used in flow cytometry on human samples (fig st1). Exp Cell Res (2016) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; fig 2
BD Biosciences CD38 antibody (BD, 555459) was used in flow cytometry on human samples (fig 2). Oncoimmunology (2016) ncbi
mouse monoclonal (HB7)
  • flow cytometry; human; loading ...; fig 7c
BD Biosciences CD38 antibody (Becton Dickinson, 345806) was used in flow cytometry on human samples (fig 7c). BMC Biotechnol (2016) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; loading ...; tbl s1
In order to explore how junctional adhesion molecule family members differentially regulate CXCR4 function and CXCL12 secretion in the bone marrow niche, BD Biosciences CD38 antibody (BD Pharmingen, BD555459) was used in flow cytometry on human samples (tbl s1). Stem Cells (2016) ncbi
mouse monoclonal (HB7)
  • other; human; loading ...; fig st1
  • flow cytometry; human; loading ...; fig st3
In order to use size exclusion chromatography-microsphere-based affinity proteomics to study clinical samples obtained from pediatric acute leukemia patients, BD Biosciences CD38 antibody (BD Biosciences, HB7) was used in other on human samples (fig st1) and in flow cytometry on human samples (fig st3). Mol Cell Proteomics (2016) ncbi
mouse monoclonal (HB7)
  • flow cytometry; human; fig 1
In order to measure the expression of antigens on malignant human plasma cells that have exhibited promise in targeted cancer therapy, BD Biosciences CD38 antibody (BD, HB7) was used in flow cytometry on human samples (fig 1). Cytometry B Clin Cytom (2017) ncbi
mouse monoclonal (HB7)
  • flow cytometry; human; loading ...; fig s1a, s1b, s1c
In order to characterize oligopotent progenitors from the fetal liver, BD Biosciences CD38 antibody (BD, 335790) was used in flow cytometry on human samples (fig s1a, s1b, s1c). Science (2016) ncbi
mouse monoclonal (HB7)
  • flow cytometry; human; loading ...; fig s3
BD Biosciences CD38 antibody (BD Biosciences, HB7) was used in flow cytometry on human samples (fig s3). Sci Transl Med (2015) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human
In order to assess the role of B cells in tolerant kidney transplant recipients, BD Biosciences CD38 antibody (BD, HIT2) was used in flow cytometry on human samples . Am J Transplant (2015) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human
BD Biosciences CD38 antibody (BD Biosciences, # 555462) was used in flow cytometry on human samples . Immunol Res (2015) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; fig s4
BD Biosciences CD38 antibody (BD Biosciences, 563965) was used in flow cytometry on human samples (fig s4). Nature (2015) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; fig s5
In order to assess arming of MAIT cell cytolytic antimicrobial activity and induction by IL-7 and faulty in HIV-1 infection, BD Biosciences CD38 antibody (BD Biosciences, HIT2) was used in flow cytometry on human samples (fig s5). PLoS Pathog (2015) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human
In order to study the molecular signaling responsible for retinoic acid-induced differentiation, BD Biosciences CD38 antibody (BD Pharmingen, 555460) was used in flow cytometry on human samples . PLoS ONE (2015) ncbi
mouse monoclonal (22/CD38)
  • western blot; human
In order to study the molecular signaling responsible for retinoic acid-induced differentiation, BD Biosciences CD38 antibody (BD Pharmingen, 611114) was used in western blot on human samples . PLoS ONE (2015) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; fig 3a
BD Biosciences CD38 antibody (BD Biosciences, HIT2) was used in flow cytometry on human samples (fig 3a). PLoS Negl Trop Dis (2015) ncbi
mouse monoclonal (HIT2)
  • immunocytochemistry; human; fig 6
In order to elucidate the mechanism by which NHE-1 expression is inhibited by JAK2V617F, BD Biosciences CD38 antibody (BD Biosciences, HIT2) was used in immunocytochemistry on human samples (fig 6). Oncogene (2016) ncbi
mouse monoclonal (HB7)
  • flow cytometry; human; loading ...; tbl 1
In order to compare the use of CD229, CD54, and CD319 expression for the identification of normal and aberrant plasma cells, BD Biosciences CD38 antibody (BD, HB7) was used in flow cytometry on human samples (tbl 1). Cytometry B Clin Cytom (2016) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; fig 3
In order to investigate the dynamics and characteristics of natural killer cell types in the human ocular mucosal surface in situ during infection with group D human adenoviruses, BD Biosciences CD38 antibody (BD Biosciences, HIT2) was used in flow cytometry on human samples (fig 3). Mucosal Immunol (2016) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; fig 1
BD Biosciences CD38 antibody (BD Bioscience, 560677) was used in flow cytometry on human samples (fig 1). J Hematol Oncol (2015) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human
In order to discuss the use of stem cells to treat Wiskott-Aldrich syndrome, BD Biosciences CD38 antibody (BD, HIT2) was used in flow cytometry on human samples . J Allergy Clin Immunol (2015) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human
In order to test if macrophages contribute to the effect of daratumumab treatment, BD Biosciences CD38 antibody (BD, 555458) was used in flow cytometry on human samples . MAbs (2015) ncbi
mouse monoclonal (HB7)
  • flow cytometry; human; fig s3
BD Biosciences CD38 antibody (BD Biosciences, HB7) was used in flow cytometry on human samples (fig s3). J Immunol (2015) ncbi
mouse monoclonal (HB7)
  • flow cytometry; human; tbl s1
In order to examine the early impact of viral replicative capacity on HIV-1 immunopathogenesis, BD Biosciences CD38 antibody (BD Biosciences, HB7) was used in flow cytometry on human samples (tbl s1). Proc Natl Acad Sci U S A (2015) ncbi
mouse monoclonal (HB7)
  • flow cytometry; human; 1:100
BD Biosciences CD38 antibody (BD, 335790) was used in flow cytometry on human samples at 1:100. Cell Stem Cell (2015) ncbi
mouse monoclonal (HB7)
  • flow cytometry; human; fig 6
BD Biosciences CD38 antibody (BD Biosciences, HB7) was used in flow cytometry on human samples (fig 6). Am J Hum Genet (2015) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; fig 3
BD Biosciences CD38 antibody (BD Pharmingen, HIT2) was used in flow cytometry on human samples (fig 3). Blood (2015) ncbi
mouse monoclonal (HB7)
  • flow cytometry; human; loading ...; fig st3
In order to ascertain the impact of cell-intrinsic immunity on the latent reservoir of HIV, BD Biosciences CD38 antibody (BD Biosciences, HB7) was used in flow cytometry on human samples (fig st3). AIDS (2015) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human
BD Biosciences CD38 antibody (BD Pharmingen, HIT2) was used in flow cytometry on human samples . Clin Cancer Res (2015) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human
BD Biosciences CD38 antibody (BD, HIT2) was used in flow cytometry on human samples . Eur J Cancer (2015) ncbi
mouse monoclonal (HB7)
  • flow cytometry; human; tbl 2
In order to test if flow cytometry can be used to find mantle cell lymphoma, BD Biosciences CD38 antibody (BD Bioscience, HB7) was used in flow cytometry on human samples (tbl 2). Cytometry B Clin Cytom (2014) ncbi
mouse monoclonal (HB7)
  • flow cytometry; human
In order to assess the efficacy of using flow cytometry immunophenotyping with fine-needle aspiration cytology for the diagnosis of thyroid lymphoma, BD Biosciences CD38 antibody (BD, HB7) was used in flow cytometry on human samples . Cytometry B Clin Cytom (2015) ncbi
mouse monoclonal (HB7)
  • flow cytometry; human; 4 ul/test
BD Biosciences CD38 antibody (BD Biosciences, HB7) was used in flow cytometry on human samples at 4 ul/test. Cytometry B Clin Cytom (2014) ncbi
mouse monoclonal (HIT2)
  • immunocytochemistry; mouse
BD Biosciences CD38 antibody (PharMingen, HIT2) was used in immunocytochemistry on mouse samples . Hum Pathol (2014) ncbi
mouse monoclonal (HB7)
  • flow cytometry; human
In order to report the immune responses elicited in an outpatient Phase 2 clinical trial in which subjects were vaccinated with CVD 1208S (DeltaguaBA, Deltaset, Deltasen S. flexneri 2a), BD Biosciences CD38 antibody (BD, HB7) was used in flow cytometry on human samples . Front Immunol (2014) ncbi
mouse monoclonal (HB7)
  • flow cytometry; human
BD Biosciences CD38 antibody (BD Biosciences, HB7) was used in flow cytometry on human samples . J Immunol (2014) ncbi
mouse monoclonal (HB7)
  • flow cytometry; human
BD Biosciences CD38 antibody (BD Biosciences, HB7) was used in flow cytometry on human samples . J Clin Immunol (2014) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human
BD Biosciences CD38 antibody (BD Biosciences, HIT2) was used in flow cytometry on human samples . FASEB J (2014) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human
BD Biosciences CD38 antibody (Becton Dickinson, HIT2) was used in flow cytometry on human samples . Biomed Res Int (2014) ncbi
mouse monoclonal (HB7)
  • flow cytometry; human
BD Biosciences CD38 antibody (BD Biosciences, HB7) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; tbl 1
In order to study the effect of innate lymphoid cells on B cells, BD Biosciences CD38 antibody (BD, HIT2) was used in flow cytometry on human samples (tbl 1). Nat Immunol (2014) ncbi
mouse monoclonal (HB7)
  • flow cytometry; human; loading ...; fig 1
In order to discuss the importance of assessing immune competence in cancer patients, BD Biosciences CD38 antibody (BD, HB-7) was used in flow cytometry on human samples (fig 1). Cancer Immunol Immunother (2014) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human; loading ...; fig 1a
BD Biosciences CD38 antibody (Becton Dickinson, HIT2) was used in flow cytometry on human samples (fig 1a). Clin Immunol (2014) ncbi
mouse monoclonal (HB7)
  • flow cytometry; human; loading ...; fig 2a
In order to screen for and assess myeloma plasma cell markers, BD Biosciences CD38 antibody (BD Biosciences, HB7) was used in flow cytometry on human samples (fig 2a). Blood (2014) ncbi
mouse monoclonal (HB7)
  • flow cytometry; human
BD Biosciences CD38 antibody (BD Biosciences, HB-7) was used in flow cytometry on human samples . J Allergy Clin Immunol (2014) ncbi
mouse monoclonal (HB7)
  • flow cytometry; human; tbl 1
In order to compare fine needle aspiration cytology with flow cytometry immunophenotyping for the diagnosis of lymphoproliferative processes in the salivary glands, BD Biosciences CD38 antibody (BD, clone HB7) was used in flow cytometry on human samples (tbl 1). Cytopathology (2014) ncbi
mouse monoclonal (HIT2)
  • flow cytometry; human
BD Biosciences CD38 antibody (BD Pharmingen, HIT2) was used in flow cytometry on human samples . Genes Dev (2009) ncbi
Articles Reviewed
  1. Dr xe4 ger N, Sattler S, Huang C, Teter O, Leng K, Hashemi S, et al. A CRISPRi/a platform in human iPSC-derived microglia uncovers regulators of disease states. Nat Neurosci. 2022;25:1149-1162 pubmed publisher
  2. Ferguson I, Pati xf1 o Escobar B, Tuomivaara S, Lin Y, Nix M, Leung K, et al. The surfaceome of multiple myeloma cells suggests potential immunotherapeutic strategies and protein markers of drug resistance. Nat Commun. 2022;13:4121 pubmed publisher
  3. Hannawi Y, Ewees M, Moore J, Zweier J. Characterizing CD38 Expression and Enzymatic Activity in the Brain of Spontaneously Hypertensive Stroke-Prone Rats. Front Pharmacol. 2022;13:881708 pubmed publisher
  4. Chen P, Katsuyama E, Satyam A, Li H, Rubio J, Jung S, et al. CD38 reduces mitochondrial fitness and cytotoxic T cell response against viral infection in lupus patients by suppressing mitophagy. Sci Adv. 2022;8:eabo4271 pubmed publisher
  5. Poletto E, Colella P, Pimentel Vera L, Khan S, Tomatsu S, Baldo G, et al. Improved engraftment and therapeutic efficacy by human genome-edited hematopoietic stem cells with Busulfan-based myeloablation. Mol Ther Methods Clin Dev. 2022;25:392-409 pubmed publisher
  6. Brown G, Ca xf1 ete P, Wang H, Medhavy A, Bones J, Roco J, et al. TLR7 gain-of-function genetic variation causes human lupus. Nature. 2022;605:349-356 pubmed publisher
  7. Jiang Z, Qin L, Tang Y, Liao R, Shi J, He B, et al. Human induced-T-to-natural killer cells have potent anti-tumour activities. Biomark Res. 2022;10:13 pubmed publisher
  8. Wennerberg E, Mukherjee S, Spada S, Hung C, Agrusa C, Chen C, et al. Expression of the mono-ADP-ribosyltransferase ART1 by tumor cells mediates immune resistance in non-small cell lung cancer. Sci Transl Med. 2022;14:eabe8195 pubmed publisher
  9. Liu M, Wu C, Luo S, Hua Q, Chen H, Weng Y, et al. PERK reprograms hematopoietic progenitor cells to direct tumor-promoting myelopoiesis in the spleen. J Exp Med. 2022;219: pubmed publisher
  10. Yang M, Long D, Hu L, Zhao Z, Li Q, Guo Y, et al. AIM2 deficiency in B cells ameliorates systemic lupus erythematosus by regulating Blimp-1-Bcl-6 axis-mediated B-cell differentiation. Signal Transduct Target Ther. 2021;6:341 pubmed publisher
  11. Oberhardt V, Luxenburger H, Kemming J, Schulien I, Ciminski K, Giese S, et al. Rapid and stable mobilization of CD8+ T cells by SARS-CoV-2 mRNA vaccine. Nature. 2021;597:268-273 pubmed publisher
  12. Lejeune M, Duray E, Peipp M, Clémenceau B, Baron F, Beguin Y, et al. Balancing the CD38 Expression on Effector and Target Cells in Daratumumab-Mediated NK Cell ADCC against Multiple Myeloma. Cancers (Basel). 2021;13: pubmed publisher
  13. Amanat F, Thapa M, Lei T, Ahmed S, Adelsberg D, Carreño J, et al. SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2. Cell. 2021;184:3936-3948.e10 pubmed publisher
  14. Bohannon C, Ende Z, Cao W, Mboko W, Ranjan P, Kumar A, et al. Influenza Virus Infects and Depletes Activated Adaptive Immune Responders. Adv Sci (Weinh). 2021;8:e2100693 pubmed publisher
  15. Barker K, Etesami N, Shenoy A, Arafa E, Lyon de Ana C, Smith N, et al. Lung-resident memory B cells protect against bacterial pneumonia. J Clin Invest. 2021;131: pubmed publisher
  16. Turner J, Kim W, Kalaidina E, Goss C, Rauseo A, Schmitz A, et al. SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans. Nature. 2021;595:421-425 pubmed publisher
  17. Laurent E, Sieber A, Salzer B, Wachernig A, Seigner J, Lehner M, et al. Directed Evolution of Stabilized Monomeric CD19 for Monovalent CAR Interaction Studies and Monitoring of CAR-T Cell Patients. ACS Synth Biol. 2021;10:1184-1198 pubmed publisher
  18. Ingelfinger F, Krishnarajah S, Kramer M, Utz S, Galli E, Lutz M, et al. Single-cell profiling of myasthenia gravis identifies a pathogenic T cell signature. Acta Neuropathol. 2021;141:901-915 pubmed publisher
  19. Hirano M, Imai Y, Kaito Y, Murayama T, Sato K, Ishida T, et al. Small-molecule HDAC and Akt inhibitors suppress tumor growth and enhance immunotherapy in multiple myeloma. J Exp Clin Cancer Res. 2021;40:110 pubmed publisher
  20. Chiou S, Tseng D, Reuben A, Mallajosyula V, Molina I, Conley S, et al. Global analysis of shared T cell specificities in human non-small cell lung cancer enables HLA inference and antigen discovery. Immunity. 2021;54:586-602.e8 pubmed publisher
  21. Sokal A, Chappert P, Barba Spaeth G, Roeser A, Fourati S, Azzaoui I, et al. Maturation and persistence of the anti-SARS-CoV-2 memory B cell response. Cell. 2021;184:1201-1213.e14 pubmed publisher
  22. Biswas S, Mandal G, Payne K, Anadon C, Gatenbee C, Chaurio R, et al. IgA transcytosis and antigen recognition govern ovarian cancer immunity. Nature. 2021;591:464-470 pubmed publisher
  23. Vavassori V, Mercuri E, Marcovecchio G, Castiello M, Schiroli G, Albano L, et al. Modeling, optimization, and comparable efficacy of T cell and hematopoietic stem cell gene editing for treating hyper-IgM syndrome. EMBO Mol Med. 2021;13:e13545 pubmed publisher
  24. Gregorova M, Morse D, Brignoli T, Steventon J, Hamilton F, Albur M, et al. Post-acute COVID-19 associated with evidence of bystander T-cell activation and a recurring antibiotic-resistant bacterial pneumonia. elife. 2020;9: pubmed publisher
  25. Luo B, Zhan Y, Luo M, Dong H, Liu J, Lin Y, et al. Engineering of α-PD-1 antibody-expressing long-lived plasma cells by CRISPR/Cas9-mediated targeted gene integration. Cell Death Dis. 2020;11:973 pubmed publisher
  26. Noz M, Bekkering S, Groh L, Nielen T, Lamfers E, Schlitzer A, et al. Reprogramming of bone marrow myeloid progenitor cells in patients with severe coronary artery disease. elife. 2020;9: pubmed publisher
  27. Bhattacharya P, Ellegård R, Khalid M, Svanberg C, Govender M, Keita A, et al. Complement opsonization of HIV affects primary infection of human colorectal mucosa and subsequent activation of T cells. elife. 2020;9: pubmed publisher
  28. Tan E, Hopkins R, Lim C, Jamuar S, Ong C, Thoon K, et al. Dominant-negative NFKBIA mutation promotes IL-1β production causing hepatic disease with severe immunodeficiency. J Clin Invest. 2020;130:5817-5832 pubmed publisher
  29. Brouwer P, Caniels T, van der Straten K, Snitselaar J, Aldon Y, Bangaru S, et al. Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability. Science. 2020;369:643-650 pubmed publisher
  30. Raehtz K, Barrenas F, Xu C, Busman Sahay K, Valentine A, Law L, et al. African green monkeys avoid SIV disease progression by preventing intestinal dysfunction and maintaining mucosal barrier integrity. PLoS Pathog. 2020;16:e1008333 pubmed publisher
  31. Helmink B, Reddy S, Gao J, Zhang S, Basar R, Thakur R, et al. B cells and tertiary lymphoid structures promote immunotherapy response. Nature. 2020;577:549-555 pubmed publisher
  32. Delgobo M, Mendes D, Kozlova E, Rocha E, Rodrigues Luiz G, Mascarin L, et al. An evolutionary recent IFN/IL-6/CEBP axis is linked to monocyte expansion and tuberculosis severity in humans. elife. 2019;8: pubmed publisher
  33. Griss J, Bauer W, Wagner C, Simon M, Chen M, Grabmeier Pfistershammer K, et al. B cells sustain inflammation and predict response to immune checkpoint blockade in human melanoma. Nat Commun. 2019;10:4186 pubmed publisher
  34. Di Blasi D, Boldanova T, Mori L, Terracciano L, Heim M, De Libero G. Unique T-Cell Populations Define Immune-Inflamed Hepatocellular Carcinoma. Cell Mol Gastroenterol Hepatol. 2020;9:195-218 pubmed publisher
  35. Crank M, Ruckwardt T, Chen M, Morabito K, Phung E, Costner P, et al. A proof of concept for structure-based vaccine design targeting RSV in humans. Science. 2019;365:505-509 pubmed publisher
  36. Meckiff B, Ladell K, McLaren J, Ryan G, Leese A, James E, et al. Primary EBV Infection Induces an Acute Wave of Activated Antigen-Specific Cytotoxic CD4+ T Cells. J Immunol. 2019;203:1276-1287 pubmed publisher
  37. Shokri M, Bozorgmehr M, Ghanavatinejad A, Falak R, Aleahmad M, Kazemnejad S, et al. Human menstrual blood-derived stromal/stem cells modulate functional features of natural killer cells. Sci Rep. 2019;9:10007 pubmed publisher
  38. Nam A, Kim K, Chaligne R, Izzo F, Ang C, Taylor J, et al. Somatic mutations and cell identity linked by Genotyping of Transcriptomes. Nature. 2019;571:355-360 pubmed publisher
  39. Hill D, Pierson W, Bolland D, Mkindi C, Carr E, Wang J, et al. The adjuvant GLA-SE promotes human Tfh cell expansion and emergence of public TCRβ clonotypes. J Exp Med. 2019;: pubmed publisher
  40. Pellin D, Loperfido M, Baricordi C, Wolock S, Montepeloso A, Weinberg O, et al. A comprehensive single cell transcriptional landscape of human hematopoietic progenitors. Nat Commun. 2019;10:2395 pubmed publisher
  41. Escolano A, Gristick H, Abernathy M, Merkenschlager J, Gautam R, Oliveira T, et al. Immunization expands B cells specific to HIV-1 V3 glycan in mice and macaques. Nature. 2019;: pubmed publisher
  42. Wilkinson A, Ishida R, Kikuchi M, Sudo K, Morita M, Crisostomo R, et al. Long-term ex vivo haematopoietic-stem-cell expansion allows nonconditioned transplantation. Nature. 2019;: pubmed publisher
  43. Staniek J, Lorenzetti R, Heller B, Janowska I, Schneider P, Unger S, et al. TRAIL-R1 and TRAIL-R2 Mediate TRAIL-Dependent Apoptosis in Activated Primary Human B Lymphocytes. Front Immunol. 2019;10:951 pubmed publisher
  44. Davis C, Jackson K, McElroy A, Halfmann P, Huang J, Chennareddy C, et al. Longitudinal Analysis of the Human B Cell Response to Ebola Virus Infection. Cell. 2019;: pubmed publisher
  45. Moffett H, Harms C, Fitzpatrick K, Tooley M, Boonyaratanakornkit J, Taylor J. B cells engineered to express pathogen-specific antibodies protect against infection. Sci Immunol. 2019;4: pubmed publisher
  46. Zumaquero E, Stone S, Scharer C, Jenks S, Nellore A, Mousseau B, et al. IFNγ induces epigenetic programming of human T-bethi B cells and promotes TLR7/8 and IL-21 induced differentiation. elife. 2019;8: pubmed publisher
  47. Wagner J, Rapsomaniki M, Chevrier S, Anzeneder T, Langwieder C, Dykgers A, et al. A Single-Cell Atlas of the Tumor and Immune Ecosystem of Human Breast Cancer. Cell. 2019;177:1330-1345.e18 pubmed publisher
  48. Ye Y, Liu M, Tang L, Du F, Liu Y, Hao P, et al. Iguratimod represses B cell terminal differentiation linked with the inhibition of PKC/EGR1 axis. Arthritis Res Ther. 2019;21:92 pubmed publisher
  49. Lee S, Mayr C. Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. Mol Cell. 2019;: pubmed publisher
  50. Remmerswaal E, Hombrink P, Nota B, Pircher H, ten Berge I, van Lier R, et al. Expression of IL-7Rα and KLRG1 defines functionally distinct CD8+ T-cell populations in humans. Eur J Immunol. 2019;49:694-708 pubmed publisher
  51. de Jonge K, Ebering A, Nassiri S, Maby El Hajjami H, Ouertatani Sakouhi H, Baumgaertner P, et al. Circulating CD56bright NK cells inversely correlate with survival of melanoma patients. Sci Rep. 2019;9:4487 pubmed publisher
  52. Lu E, Wolfreys F, Muppidi J, Xu Y, Cyster J. S-Geranylgeranyl-L-glutathione is a ligand for human B cell-confinement receptor P2RY8. Nature. 2019;: pubmed publisher
  53. van Galen P, Hovestadt V, Wadsworth Ii M, Hughes T, Griffin G, Battaglia S, et al. Single-Cell RNA-Seq Reveals AML Hierarchies Relevant to Disease Progression and Immunity. Cell. 2019;176:1265-1281.e24 pubmed publisher
  54. Kriegsmann K, Baertsch M, Awwad M, Merz M, Hose D, Seckinger A, et al. Cereblon-binding proteins expression levels correlate with hyperdiploidy in newly diagnosed multiple myeloma patients. Blood Cancer J. 2019;9:13 pubmed publisher
  55. Montel Hagen A, Seet C, Li S, Chick B, Zhu Y, Chang P, et al. Organoid-Induced Differentiation of Conventional T Cells from Human Pluripotent Stem Cells. Cell Stem Cell. 2019;24:376-389.e8 pubmed publisher
  56. Ge Y, Schuster M, Pundhir S, Rapin N, Bagger F, Sidiropoulos N, et al. The splicing factor RBM25 controls MYC activity in acute myeloid leukemia. Nat Commun. 2019;10:172 pubmed publisher
  57. Perciani C, Farah B, Kaul R, Ostrowski M, Mahmud S, Anzala O, et al. Live attenuated varicella-zoster virus vaccine does not induce HIV target cell activation. J Clin Invest. 2019;129:875-886 pubmed publisher
  58. Bradley T, Peppa D, Pedroza Pacheco I, Li D, Cain D, Henao R, et al. RAB11FIP5 Expression and Altered Natural Killer Cell Function Are Associated with Induction of HIV Broadly Neutralizing Antibody Responses. Cell. 2018;175:387-399.e17 pubmed publisher
  59. Al Maskari M, Care M, Robinson E, Cocco M, Tooze R, Doody G. Site-1 protease function is essential for the generation of antibody secreting cells and reprogramming for secretory activity. Sci Rep. 2018;8:14338 pubmed publisher
  60. Dam E, Maier A, Hocking A, Carlin J, Buckner J. Increased Binding of Specificity Protein 1 to the IL21R Promoter in B Cells Results in Enhanced B Cell Responses in Rheumatoid Arthritis. Front Immunol. 2018;9:1978 pubmed publisher
  61. Olin A, Henckel E, Chen Y, Lakshmikanth T, Pou C, Mikes J, et al. Stereotypic Immune System Development in Newborn Children. Cell. 2018;174:1277-1292.e14 pubmed publisher
  62. Tai Y, Lin L, Xing L, Cho S, Yu T, Acharya C, et al. APRIL signaling via TACI mediates immunosuppression by T regulatory cells in multiple myeloma: therapeutic implications. Leukemia. 2019;33:426-438 pubmed publisher
  63. Burton A, Pallett L, McCoy L, Suveizdyte K, Amin O, Swadling L, et al. Circulating and intrahepatic antiviral B cells are defective in hepatitis B. J Clin Invest. 2018;128:4588-4603 pubmed publisher
  64. Heshmati Y, Kharazi S, Türköz G, Chang D, Kamali Dolatabadi E, Boström J, et al. The histone chaperone NAP1L3 is required for haematopoietic stem cell maintenance and differentiation. Sci Rep. 2018;8:11202 pubmed publisher
  65. Moysi E, Pallikkuth S, de Armas L, Gonzalez L, Ambrozak D, George V, et al. Altered immune cell follicular dynamics in HIV infection following influenza vaccination. J Clin Invest. 2018;128:3171-3185 pubmed publisher
  66. Weniger M, Tiacci E, Schneider S, Arnolds J, Rüschenbaum S, Duppach J, et al. Human CD30+ B cells represent a unique subset related to Hodgkin lymphoma cells. J Clin Invest. 2018;128:2996-3007 pubmed publisher
  67. Ferrara F, Kolnik M, D Angelo S, Erasmus F, Vorholt D, Bradbury A. Rapid purification of billions of circulating CD19+ B cells directly from leukophoresis samples. N Biotechnol. 2018;46:14-21 pubmed publisher
  68. Baumgartner C, Toifl S, Farlik M, Halbritter F, Scheicher R, Fischer I, et al. An ERK-Dependent Feedback Mechanism Prevents Hematopoietic Stem Cell Exhaustion. Cell Stem Cell. 2018;22:879-892.e6 pubmed publisher
  69. Sullivan N, Reuter Monslow M, Sei J, Durr E, Davis C, Chang C, et al. Breadth and Functionality of Varicella-Zoster Virus Glycoprotein-Specific Antibodies Identified after Zostavax Vaccination in Humans. J Virol. 2018;92: pubmed publisher
  70. Roders N, Herr F, Ambroise G, Thaunat O, Portier A, Vazquez A, et al. SYK Inhibition Induces Apoptosis in Germinal Center-Like B Cells by Modulating the Antiapoptotic Protein Myeloid Cell Leukemia-1, Affecting B-Cell Activation and Antibody Production. Front Immunol. 2018;9:787 pubmed publisher
  71. Zhang Y, Xia F, Liu X, Yu Z, Xie L, Liu L, et al. JAM3 maintains leukemia-initiating cell self-renewal through LRP5/AKT/?-catenin/CCND1 signaling. J Clin Invest. 2018;128:1737-1751 pubmed publisher
  72. Khajuria R, Munschauer M, Ulirsch J, Fiorini C, Ludwig L, McFarland S, et al. Ribosome Levels Selectively Regulate Translation and Lineage Commitment in Human Hematopoiesis. Cell. 2018;173:90-103.e19 pubmed publisher
  73. Zhang B, Nguyen L, Li L, Zhao D, Kumar B, Wu H, et al. Bone marrow niche trafficking of miR-126 controls the self-renewal of leukemia stem cells in chronic myelogenous leukemia. Nat Med. 2018;24:450-462 pubmed publisher
  74. Gee M, Han A, Lofgren S, Beausang J, Mendoza J, Birnbaum M, et al. Antigen Identification for Orphan T Cell Receptors Expressed on Tumor-Infiltrating Lymphocytes. Cell. 2018;172:549-563.e16 pubmed publisher
  75. Wu X, Dao Thi V, Huang Y, Billerbeck E, Saha D, Hoffmann H, et al. Intrinsic Immunity Shapes Viral Resistance of Stem Cells. Cell. 2018;172:423-438.e25 pubmed publisher
  76. Amodio D, Cotugno N, Macchiarulo G, Rocca S, Dimopoulos Y, Castrucci M, et al. Quantitative Multiplexed Imaging Analysis Reveals a Strong Association between Immunogen-Specific B Cell Responses and Tonsillar Germinal Center Immune Dynamics in Children after Influenza Vaccination. J Immunol. 2018;200:538-550 pubmed publisher
  77. Macdonald R, Shrimp J, Jiang H, Zhang L, Lin H, Yen A. Probing the requirement for CD38 in retinoic acid-induced HL-60 cell differentiation with a small molecule dimerizer and genetic knockout. Sci Rep. 2017;7:17406 pubmed publisher
  78. Buffone A, Anderson N, Hammer D. Migration against the direction of flow is LFA-1-dependent in human hematopoietic stem and progenitor cells. J Cell Sci. 2018;131: pubmed publisher
  79. Arthur Huang K, Chen M, Huang Y, Shih S, Chiu C, Lin J, et al. Epitope-associated and specificity-focused features of EV71-neutralizing antibody repertoires from plasmablasts of infected children. Nat Commun. 2017;8:762 pubmed publisher
  80. Salio M, Gasser O, González López C, Martens A, Veerapen N, Gileadi U, et al. Activation of Human Mucosal-Associated Invariant T Cells Induces CD40L-Dependent Maturation of Monocyte-Derived and Primary Dendritic Cells. J Immunol. 2017;199:2631-2638 pubmed publisher
  81. Papa I, Saliba D, Ponzoni M, Bustamante S, Canete P, Gonzalez Figueroa P, et al. TFH-derived dopamine accelerates productive synapses in germinal centres. Nature. 2017;547:318-323 pubmed publisher
  82. Shah F, Stepan A, O Mahony A, Velichko S, Folias A, Houle C, et al. Mechanisms of Skin Toxicity Associated with Metabotropic Glutamate Receptor 5 Negative Allosteric Modulators. Cell Chem Biol. 2017;24:858-869.e5 pubmed publisher
  83. Arumugakani G, Stephenson S, Newton D, Rawstron A, Emery P, Doody G, et al. Early Emergence of CD19-Negative Human Antibody-Secreting Cells at the Plasmablast to Plasma Cell Transition. J Immunol. 2017;198:4618-4628 pubmed publisher
  84. Chevrier S, Levine J, Zanotelli V, Silina K, Schulz D, Bacac M, et al. An Immune Atlas of Clear Cell Renal Cell Carcinoma. Cell. 2017;169:736-749.e18 pubmed publisher
  85. See P, Dutertre C, Chen J, Günther P, McGovern N, Irac S, et al. Mapping the human DC lineage through the integration of high-dimensional techniques. Science. 2017;356: pubmed publisher
  86. Pérez Martínez C, Maravillas Montero J, Meza Herrera I, Vences Catalan F, Zlotnik A, Santos Argumedo L. Tspan33 is Expressed in Transitional and Memory B Cells, but is not Responsible for High ADAM10 Expression. Scand J Immunol. 2017;86:23-30 pubmed publisher
  87. Dourado K, Baik J, Oliveira V, Beltrame M, Yamamoto A, Theuer C, et al. Endoglin: a novel target for therapeutic intervention in acute leukemias revealed in xenograft mouse models. Blood. 2017;129:2526-2536 pubmed publisher
  88. Lu X, Horner J, Paul E, Shang X, Troncoso P, Deng P, et al. Effective combinatorial immunotherapy for castration-resistant prostate cancer. Nature. 2017;543:728-732 pubmed publisher
  89. Pinto Cardoso S, Lozupone C, Briceno O, Alva Hernández S, Téllez N, Adriana A, et al. Fecal Bacterial Communities in treated HIV infected individuals on two antiretroviral regimens. Sci Rep. 2017;7:43741 pubmed publisher
  90. Vernot J, Bonilla X, Rodriguez Pardo V, Vanegas N. Phenotypic and Functional Alterations of Hematopoietic Stem and Progenitor Cells in an In Vitro Leukemia-Induced Microenvironment. Int J Mol Sci. 2017;18: pubmed publisher
  91. Mordmuller B, Surat G, Lagler H, Chakravarty S, Ishizuka A, Lalremruata A, et al. Sterile protection against human malaria by chemoattenuated PfSPZ vaccine. Nature. 2017;542:445-449 pubmed publisher
  92. Rao D, Gurish M, Marshall J, Slowikowski K, Fonseka C, Liu Y, et al. Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis. Nature. 2017;542:110-114 pubmed publisher
  93. Salvatori G, Foligno S, Sirleto P, Genovese S, Russo S, Coletti V, et al. Sometimes it is better to wait: First Italian case of a newborn with transient abnormal myelopoiesis and a favorable prognosis. Oncol Lett. 2017;13:191-195 pubmed publisher
  94. Wentink M, Dalm V, Lankester A, van Schouwenburg P, Schölvinck L, Kalina T, et al. Genetic defects in PI3K? affect B-cell differentiation and maturation leading to hypogammaglobulineamia and recurrent infections. Clin Immunol. 2017;176:77-86 pubmed publisher
  95. Tauriainen J, Scharf L, Frederiksen J, Naji A, Ljunggren H, Sonnerborg A, et al. Perturbed CD8+ T cell TIGIT/CD226/PVR axis despite early initiation of antiretroviral treatment in HIV infected individuals. Sci Rep. 2017;7:40354 pubmed publisher
  96. Lundell A, Nordström I, Andersson K, Lundqvist C, Telemo E, Nava S, et al. IFN type I and II induce BAFF secretion from human decidual stromal cells. Sci Rep. 2017;7:39904 pubmed publisher
  97. van Andel H, Ren Z, Koopmans I, Joosten S, Kocemba K, de Lau W, et al. Aberrantly expressed LGR4 empowers Wnt signaling in multiple myeloma by hijacking osteoblast-derived R-spondins. Proc Natl Acad Sci U S A. 2017;114:376-381 pubmed publisher
  98. Fromm J, Thomas A, Wood B. Characterization and Purification of Neoplastic Cells of Nodular Lymphocyte Predominant Hodgkin Lymphoma from Lymph Nodes by Flow Cytometry and Flow Cytometric Cell Sorting. Am J Pathol. 2017;187:304-317 pubmed publisher
  99. Cheng L, Ma J, Li J, Li D, Li G, Li F, et al. Blocking type I interferon signaling enhances T cell recovery and reduces HIV-1 reservoirs. J Clin Invest. 2017;127:269-279 pubmed publisher
  100. Zhen A, Rezek V, Youn C, Lam B, Chang N, Rick J, et al. Targeting type I interferon-mediated activation restores immune function in chronic HIV infection. J Clin Invest. 2017;127:260-268 pubmed publisher
  101. Matsuoka Y, Takahashi M, Sumide K, Kawamura H, Nakatsuka R, Fujioka T, et al. CD34 Antigen and the MPL Receptor Expression Defines a Novel Class of Human Cord Blood-Derived Primitive Hematopoietic Stem Cells. Cell Transplant. 2017;26:1043-1058 pubmed publisher
  102. Ng S, Mitchell A, Kennedy J, Chen W, McLeod J, Ibrahimova N, et al. A 17-gene stemness score for rapid determination of risk in acute leukaemia. Nature. 2016;540:433-437 pubmed publisher
  103. Briceno O, Pinto Cardoso S, Rodríguez Bernabe N, Murakami Ogasawara A, Reyes Teran G. Gut Homing CD4+ and CD8+ T-Cell Frequencies in HIV Infected Individuals on Antiretroviral Treatment. PLoS ONE. 2016;11:e0166496 pubmed publisher
  104. Sherbenou D, Aftab B, Su Y, Behrens C, Wiita A, Logan A, et al. Antibody-drug conjugate targeting CD46 eliminates multiple myeloma cells. J Clin Invest. 2016;126:4640-4653 pubmed publisher
  105. Dever D, Bak R, Reinisch A, Camarena J, Washington G, Nicolas C, et al. CRISPR/Cas9 β-globin gene targeting in human haematopoietic stem cells. Nature. 2016;539:384-389 pubmed publisher
  106. Sumatoh H, Teng K, Cheng Y, Newell E. Optimization of mass cytometry sample cryopreservation after staining. Cytometry A. 2017;91:48-61 pubmed publisher
  107. Dyer W, Tan J, Day T, Kiers L, Kiernan M, Yiannikas C, et al. Immunomodulation of inflammatory leukocyte markers during intravenous immunoglobulin treatment associated with clinical efficacy in chronic inflammatory demyelinating polyradiculoneuropathy. Brain Behav. 2016;6:e00516 pubmed
  108. Fatehchand K, McMichael E, Reader B, Fang H, Santhanam R, Gautam S, et al. Interferon-γ Promotes Antibody-mediated Fratricide of Acute Myeloid Leukemia Cells. J Biol Chem. 2016;291:25656-25666 pubmed
  109. Chandele A, Sewatanon J, Gunisetty S, Singla M, Onlamoon N, Akondy R, et al. Characterization of Human CD8 T Cell Responses in Dengue Virus-Infected Patients from India. J Virol. 2016;90:11259-11278 pubmed
  110. Oon S, Huynh H, Tai T, Ng M, Monaghan K, Biondo M, et al. A cytotoxic anti-IL-3Rα antibody targets key cells and cytokines implicated in systemic lupus erythematosus. JCI Insight. 2016;1:e86131 pubmed publisher
  111. Alivernini S, Kurowska Stolarska M, Tolusso B, Benvenuto R, Elmesmari A, Canestri S, et al. MicroRNA-155 influences B-cell function through PU.1 in rheumatoid arthritis. Nat Commun. 2016;7:12970 pubmed publisher
  112. Clavarino G, Delouche N, Vettier C, Laurin D, Pernollet M, Raskovalova T, et al. Novel Strategy for Phenotypic Characterization of Human B Lymphocytes from Precursors to Effector Cells by Flow Cytometry. PLoS ONE. 2016;11:e0162209 pubmed publisher
  113. Keefer M, Zheng B, Rosenberg A, Kobie J. Increased Steady-State Memory B Cell Subsets Among High-Risk Participants in an HIV Vaccine Trial. AIDS Res Hum Retroviruses. 2016;32:1143-1148 pubmed
  114. Lu X, Chen Q, Rong Y, Yang G, Li C, Xu N, et al. LECT2 drives haematopoietic stem cell expansion and mobilization via regulating the macrophages and osteolineage cells. Nat Commun. 2016;7:12719 pubmed publisher
  115. Ferre E, Rose S, Rosenzweig S, Burbelo P, Romito K, Niemela J, et al. Redefined clinical features and diagnostic criteria in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. JCI Insight. 2016;1: pubmed
  116. Toro J, Salgado D, Vega R, Rodríguez J, Rodríguez L, Angel J, et al. Total and Envelope Protein-Specific Antibody-Secreting Cell Response in Pediatric Dengue Is Highly Modulated by Age and Subsequent Infections. PLoS ONE. 2016;11:e0161795 pubmed publisher
  117. Neumann L, Mueller M, Moos V, Heller F, Meyer T, Loddenkemper C, et al. Mucosal Inducible NO Synthase-Producing IgA+ Plasma Cells in Helicobacter pylori-Infected Patients. J Immunol. 2016;197:1801-8 pubmed publisher
  118. Coccaro N, Tota G, Anelli L, Zagaria A, Casieri P, Cellamare A, et al. MYEOV gene overexpression in primary plasma cell leukemia with t(11;14)(q13;q32). Oncol Lett. 2016;12:1460-1464 pubmed
  119. Piepenbrink M, Samuel M, Zheng B, Carter B, Fucile C, Bunce C, et al. Humoral Dysregulation Associated with Increased Systemic Inflammation among Injection Heroin Users. PLoS ONE. 2016;11:e0158641 pubmed publisher
  120. Ebert L, Tan L, Johan M, Min K, Cockshell M, Parham K, et al. A non-canonical role for desmoglein-2 in endothelial cells: implications for neoangiogenesis. Angiogenesis. 2016;19:463-86 pubmed publisher
  121. van Wilgenburg B, Scherwitzl I, Hutchinson E, Leng T, Kurioka A, Kulicke C, et al. MAIT cells are activated during human viral infections. Nat Commun. 2016;7:11653 pubmed publisher
  122. Nejedlá M, Sadi S, Sulimenko V, de Almeida F, Blom H, Draber P, et al. Profilin connects actin assembly with microtubule dynamics. Mol Biol Cell. 2016;27:2381-93 pubmed publisher
  123. van der Heiden M, van Zelm M, Bartol S, de Rond L, Berbers G, Boots A, et al. Differential effects of Cytomegalovirus carriage on the immune phenotype of middle-aged males and females. Sci Rep. 2016;6:26892 pubmed publisher
  124. Sinclair A, Park L, Shah M, Drotar M, Calaminus S, Hopcroft L, et al. CXCR2 and CXCL4 regulate survival and self-renewal of hematopoietic stem/progenitor cells. Blood. 2016;128:371-83 pubmed publisher
  125. Reinisch A, Thomas D, Corces M, Zhang X, Gratzinger D, Hong W, et al. A humanized bone marrow ossicle xenotransplantation model enables improved engraftment of healthy and leukemic human hematopoietic cells. Nat Med. 2016;22:812-21 pubmed publisher
  126. Dou D, Calvanese V, Sierra M, Nguyen A, Minasian A, Saarikoski P, et al. Medial HOXA genes demarcate haematopoietic stem cell fate during human development. Nat Cell Biol. 2016;18:595-606 pubmed publisher
  127. Yu C, Liu Y, Chan J, Tong J, Li Z, Shi M, et al. Identification of human plasma cells with a lamprey monoclonal antibody. JCI Insight. 2016;1: pubmed
  128. Ruibal P, Oestereich L, Lüdtke A, Becker Ziaja B, Wozniak D, Kerber R, et al. Unique human immune signature of Ebola virus disease in Guinea. Nature. 2016;533:100-4 pubmed publisher
  129. Rentas S, Holzapfel N, Belew M, Pratt G, Voisin V, Wilhelm B, et al. Musashi-2 attenuates AHR signalling to expand human haematopoietic stem cells. Nature. 2016;532:508-511 pubmed publisher
  130. Saxena S, Ronn R, Guibentif C, Moraghebi R, Woods N. Cyclic AMP Signaling through Epac Axis Modulates Human Hemogenic Endothelium and Enhances Hematopoietic Cell Generation. Stem Cell Reports. 2016;6:692-703 pubmed publisher
  131. Lisenko K, Schonland S, Jauch A, Andrulis M, Rocken C, Ho A, et al. Flow cytometry-based characterization of underlying clonal B and plasma cells in patients with light chain amyloidosis. Cancer Med. 2016;5:1464-72 pubmed publisher
  132. Belov L, Matic K, Hallal S, Best O, Mulligan S, Christopherson R. Extensive surface protein profiles of extracellular vesicles from cancer cells may provide diagnostic signatures from blood samples. J Extracell Vesicles. 2016;5:25355 pubmed publisher
  133. Yamashita K, Kawata K, Matsumiya H, Kamekura R, Jitsukawa S, Nagaya T, et al. Bob1 limits cellular frequency of T-follicular helper cells. Eur J Immunol. 2016;46:1361-70 pubmed publisher
  134. Li H, Borrego F, Nagata S, Tolnay M. Fc Receptor-like 5 Expression Distinguishes Two Distinct Subsets of Human Circulating Tissue-like Memory B Cells. J Immunol. 2016;196:4064-74 pubmed publisher
  135. Jackson S, Jacobs H, Arkatkar T, Dam E, Scharping N, Kolhatkar N, et al. B cell IFN-γ receptor signaling promotes autoimmune germinal centers via cell-intrinsic induction of BCL-6. J Exp Med. 2016;213:733-50 pubmed publisher
  136. Malkiel S, Jeganathan V, Wolfson S, Manjarrez Orduno N, Marasco E, Aranow C, et al. Checkpoints for Autoreactive B Cells in the Peripheral Blood of Lupus Patients Assessed by Flow Cytometry. Arthritis Rheumatol. 2016;68:2210-20 pubmed publisher
  137. Jourdan M, Cren M, Schafer P, Robert N, Duperray C, Vincent L, et al. Differential effects of lenalidomide during plasma cell differentiation. Oncotarget. 2016;7:28096-111 pubmed publisher
  138. Brown P, Gascoyne D, Lyne L, Spearman H, Felce S, McFadden N, et al. N-terminally truncated FOXP1 protein expression and alternate internal FOXP1 promoter usage in normal and malignant B cells. Haematologica. 2016;101:861-71 pubmed publisher
  139. Mohiuddin M, Singh A, Corcoran P, Thomas Iii M, Clark T, Lewis B, et al. Chimeric 2C10R4 anti-CD40 antibody therapy is critical for long-term survival of GTKO.hCD46.hTBM pig-to-primate cardiac xenograft. Nat Commun. 2016;7:11138 pubmed publisher
  140. Griffiths K, Dolezal O, Cao B, Nilsson S, See H, Pfleger K, et al. i-bodies, Human Single Domain Antibodies That Antagonize Chemokine Receptor CXCR4. J Biol Chem. 2016;291:12641-57 pubmed publisher
  141. Lee J, Han A, Lee S, Min W, Kim H. Co-culture with podoplanin+ cells protects leukemic blast cells with leukemia-associated antigens in the tumor microenvironment. Mol Med Rep. 2016;13:3849-57 pubmed publisher
  142. Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9 pubmed publisher
  143. Flint S, Gibson A, Lucas G, Nandigam R, Taylor L, Provan D, et al. A distinct plasmablast and naïve B-cell phenotype in primary immune thrombocytopenia. Haematologica. 2016;101:698-706 pubmed publisher
  144. Gao J, Duan Z, Zhang L, Huang X, Long L, Tu J, et al. Failure recovery of circulating NKG2D+CD56dimNK cells in HBV-associated hepatocellular carcinoma after hepatectomy predicts early recurrence. Oncoimmunology. 2016;5:e1048061 pubmed
  145. Klose D, Saunders U, Barth S, Fischer R, Jacobi A, Nachreiner T. Novel fusion proteins for the antigen-specific staining and elimination of B cell receptor-positive cell populations demonstrated by a tetanus toxoid fragment C (TTC) model antigen. BMC Biotechnol. 2016;16:18 pubmed publisher
  146. Chang C, Hale S, Cox C, Blair A, Kronsteiner B, Grabowska R, et al. Junctional Adhesion Molecule-A Is Highly Expressed on Human Hematopoietic Repopulating Cells and Associates with the Key Hematopoietic Chemokine Receptor CXCR4. Stem Cells. 2016;34:1664-78 pubmed publisher
  147. Llibre A, López Macías C, Marafioti T, Mehta H, Partridge A, Kanzig C, et al. LLT1 and CD161 Expression in Human Germinal Centers Promotes B Cell Activation and CXCR4 Downregulation. J Immunol. 2016;196:2085-94 pubmed publisher
  148. James E, Gates T, LaFond R, Yamamoto S, Ni C, Mai D, et al. Neuroinvasive West Nile Infection Elicits Elevated and Atypically Polarized T Cell Responses That Promote a Pathogenic Outcome. PLoS Pathog. 2016;12:e1005375 pubmed publisher
  149. Kanderová V, Kuzilkova D, Stuchly J, Vaskova M, Brdicka T, Fiser K, et al. High-resolution Antibody Array Analysis of Childhood Acute Leukemia Cells. Mol Cell Proteomics. 2016;15:1246-61 pubmed publisher
  150. Gonzalez S, Taborda N, Correa L, Castro G, Hernandez J, Montoya C, et al. Particular activation phenotype of T cells expressing HLA-DR but not CD38 in GALT from HIV-controllers is associated with immune regulation and delayed progression to AIDS. Immunol Res. 2016;64:765-74 pubmed publisher
  151. Lisenko K, Schönland S, Hegenbart U, Wallenwein K, Braun U, Mai E, et al. Potential therapeutic targets in plasma cell disorders: A flow cytometry study. Cytometry B Clin Cytom. 2017;92:145-152 pubmed publisher
  152. Notta F, Zandi S, Takayama N, Dobson S, Gan O, Wilson G, et al. Distinct routes of lineage development reshape the human blood hierarchy across ontogeny. Science. 2016;351:aab2116 pubmed publisher
  153. Jackson J, Taylor J, Witek M, Hunsucker S, Waugh J, Fedoriw Y, et al. Microfluidics for the detection of minimal residual disease in acute myeloid leukemia patients using circulating leukemic cells selected from blood. Analyst. 2016;141:640-51 pubmed publisher
  154. Li R, Rezk A, Miyazaki Y, Hilgenberg E, Touil H, Shen P, et al. Proinflammatory GM-CSF-producing B cells in multiple sclerosis and B cell depletion therapy. Sci Transl Med. 2015;7:310ra166 pubmed publisher
  155. Newell K, Asare A, Sanz I, Wei C, Rosenberg A, Gao Z, et al. Longitudinal studies of a B cell-derived signature of tolerance in renal transplant recipients. Am J Transplant. 2015;15:2908-20 pubmed publisher
  156. Schulz A, Mälzer J, Domingo C, Jürchott K, Grützkau A, Babel N, et al. Low Thymic Activity and Dendritic Cell Numbers Are Associated with the Immune Response to Primary Viral Infection in Elderly Humans. J Immunol. 2015;195:4699-711 pubmed publisher
  157. Monahan R, Stein A, Gibbs K, Bank M, Bloom O. Circulating T cell subsets are altered in individuals with chronic spinal cord injury. Immunol Res. 2015;63:3-10 pubmed publisher
  158. Okoye Okafor U, Bartholdy B, Cartier J, Gao E, Pietrak B, Rendina A, et al. New IDH1 mutant inhibitors for treatment of acute myeloid leukemia. Nat Chem Biol. 2015;11:878-86 pubmed publisher
  159. Frederiksen J, Buggert M, Noyan K, Nowak P, Sönnerborg A, Lund O, et al. Multidimensional Clusters of CD4+ T Cell Dysfunction Are Primarily Associated with the CD4/CD8 Ratio in Chronic HIV Infection. PLoS ONE. 2015;10:e0137635 pubmed publisher
  160. Fong C, Gilan O, Lam E, Rubin A, Ftouni S, Tyler D, et al. BET inhibitor resistance emerges from leukaemia stem cells. Nature. 2015;525:538-42 pubmed publisher
  161. Leeansyah E, Svärd J, Dias J, Buggert M, Nyström J, Quigley M, et al. Arming of MAIT Cell Cytolytic Antimicrobial Activity Is Induced by IL-7 and Defective in HIV-1 Infection. PLoS Pathog. 2015;11:e1005072 pubmed publisher
  162. Japp A, Kursunel M, Meier S, Mälzer J, Li X, Rahman N, et al. Dysfunction of PSA-specific CD8+ T cells in prostate cancer patients correlates with CD38 and Tim-3 expression. Cancer Immunol Immunother. 2015;64:1487-94 pubmed publisher
  163. Bunaciu R, Jensen H, Macdonald R, Latocha D, Varner J, Yen A. 6-Formylindolo(3,2-b)Carbazole (FICZ) Modulates the Signalsome Responsible for RA-Induced Differentiation of HL-60 Myeloblastic Leukemia Cells. PLoS ONE. 2015;10:e0135668 pubmed publisher
  164. Lorkova L, Scigelova M, Arrey T, Vit O, Pospisilova J, Doktorova E, et al. Detailed Functional and Proteomic Characterization of Fludarabine Resistance in Mantle Cell Lymphoma Cells. PLoS ONE. 2015;10:e0135314 pubmed publisher
  165. Chen X, Li W, Zhang Y, Song X, Xu L, Xu Z, et al. Distribution of Peripheral Memory T Follicular Helper Cells in Patients with Schistosomiasis Japonica. PLoS Negl Trop Dis. 2015;9:e0004015 pubmed publisher
  166. Nishioka C, Ikezoe T, Takeuchi A, Nobumoto A, Tsuda M, Yokoyama A. The novel function of CD82 and its impact on BCL2L12 via AKT/STAT5 signal pathway in acute myelogenous leukemia cells. Leukemia. 2015;29:2296-306 pubmed publisher
  167. Ahn J, Li J, Chen E, Kent D, Park H, Green A. JAK2V617F mediates resistance to DNA damage-induced apoptosis by modulating FOXO3A localization and Bcl-xL deamidation. Oncogene. 2016;35:2235-46 pubmed publisher
  168. Pojero F, Flores Montero J, Sanoja L, Pérez J, Puig N, Paiva B, et al. Utility of CD54, CD229, and CD319 for the identification of plasma cells in patients with clonal plasma cell diseases. Cytometry B Clin Cytom. 2016;90:91-100 pubmed publisher
  169. Yawata N, Selva K, Liu Y, Tan K, Lee A, Siak J, et al. Dynamic change in natural killer cell type in the human ocular mucosa in situ as means of immune evasion by adenovirus infection. Mucosal Immunol. 2016;9:159-70 pubmed publisher
  170. Lee J, Breton G, Aljoufi A, Zhou Y, PUHR S, Nussenzweig M, et al. Clonal analysis of human dendritic cell progenitor using a stromal cell culture. J Immunol Methods. 2015;425:21-6 pubmed publisher
  171. Grieco A, Billett H, Green N, Driscoll M, Bouhassira E. Variation in Gamma-Globin Expression before and after Induction with Hydroxyurea Associated with BCL11A, KLF1 and TAL1. PLoS ONE. 2015;10:e0129431 pubmed publisher
  172. Mathur R, Sehgal L, Braun F, Berkova Z, Romaguerra J, Wang M, et al. Targeting Wnt pathway in mantle cell lymphoma-initiating cells. J Hematol Oncol. 2015;8:63 pubmed publisher
  173. Boisson B, Laplantine E, Dobbs K, Cobat A, Tarantino N, Hazen M, et al. Human HOIP and LUBAC deficiency underlies autoinflammation, immunodeficiency, amylopectinosis, and lymphangiectasia. J Exp Med. 2015;212:939-51 pubmed publisher
  174. Holzapfel B, Hutmacher D, Nowlan B, Barbier V, Thibaudeau L, Theodoropoulos C, et al. Tissue engineered humanized bone supports human hematopoiesis in vivo. Biomaterials. 2015;61:103-14 pubmed publisher
  175. Fromm J, Tagliente D, Shaver A, Neppalli V, Craig F. Case study interpretation: Report from the ICCS Annual Meeting, Seattle, 2014. Cytometry B Clin Cytom. 2015;88:413-24 pubmed publisher
  176. Weinberg A, Muresan P, Richardson K, Fenton T, Domínguez T, Bloom A, et al. Determinants of vaccine immunogenicity in HIV-infected pregnant women: analysis of B and T cell responses to pandemic H1N1 monovalent vaccine. PLoS ONE. 2015;10:e0122431 pubmed publisher
  177. Esch M, Prot J, Wang Y, Miller P, Llamas Vidales J, NAUGHTON B, et al. Multi-cellular 3D human primary liver cell culture elevates metabolic activity under fluidic flow. Lab Chip. 2015;15:2269-77 pubmed publisher
  178. Castiello M, Scaramuzza S, Pala F, Ferrua F, Uva P, Brigida I, et al. B-cell reconstitution after lentiviral vector-mediated gene therapy in patients with Wiskott-Aldrich syndrome. J Allergy Clin Immunol. 2015;136:692-702.e2 pubmed publisher
  179. Tian X, Zhang A, Qiu C, Wang W, Yang Y, Qiu C, et al. The upregulation of LAG-3 on T cells defines a subpopulation with functional exhaustion and correlates with disease progression in HIV-infected subjects. J Immunol. 2015;194:3873-82 pubmed publisher
  180. Overdijk M, Verploegen S, Bögels M, van Egmond M, Lammerts van Bueren J, Mutis T, et al. Antibody-mediated phagocytosis contributes to the anti-tumor activity of the therapeutic antibody daratumumab in lymphoma and multiple myeloma. MAbs. 2015;7:311-21 pubmed publisher
  181. Inui M, Hirota S, Hirano K, Fujii H, Sugahara Tobinai A, Ishii T, et al. Human CD43+ B cells are closely related not only to memory B cells phenotypically but also to plasmablasts developmentally in healthy individuals. Int Immunol. 2015;27:345-55 pubmed publisher
  182. Tsai C, Liong K, Gunalan M, Li N, Lim D, Fisher D, et al. Type I IFNs and IL-18 regulate the antiviral response of primary human γδ T cells against dendritic cells infected with Dengue virus. J Immunol. 2015;194:3890-900 pubmed publisher
  183. Claiborne D, Prince J, Scully E, Macharia G, Micci L, Lawson B, et al. Replicative fitness of transmitted HIV-1 drives acute immune activation, proviral load in memory CD4+ T cells, and disease progression. Proc Natl Acad Sci U S A. 2015;112:E1480-9 pubmed publisher
  184. Laurenti E, Frelin C, Xie S, Ferrari R, Dunant C, Zandi S, et al. CDK6 levels regulate quiescence exit in human hematopoietic stem cells. Cell Stem Cell. 2015;16:302-13 pubmed publisher
  185. Lewis M, Vyse S, Shields A, Boeltz S, Gordon P, Spector T, et al. UBE2L3 polymorphism amplifies NF-κB activation and promotes plasma cell development, linking linear ubiquitination to multiple autoimmune diseases. Am J Hum Genet. 2015;96:221-34 pubmed publisher
  186. Rissiek A, Baumann I, Cuapio A, Mautner A, Kolster M, Arck P, et al. The expression of CD39 on regulatory T cells is genetically driven and further upregulated at sites of inflammation. J Autoimmun. 2015;58:12-20 pubmed publisher
  187. de Masson A, Bouaziz J, Le Buanec H, Robin M, O Meara A, Parquet N, et al. CD24(hi)CD27⁺ and plasmablast-like regulatory B cells in human chronic graft-versus-host disease. Blood. 2015;125:1830-9 pubmed publisher
  188. Abdel Mohsen M, Wang C, Strain M, Lada S, Deng X, Cockerham L, et al. Select host restriction factors are associated with HIV persistence during antiretroviral therapy. AIDS. 2015;29:411-20 pubmed publisher
  189. Johnson P, Challis R, Chowdhury F, Gao Y, Harvey M, Geldart T, et al. Clinical and biological effects of an agonist anti-CD40 antibody: a Cancer Research UK phase I study. Clin Cancer Res. 2015;21:1321-8 pubmed publisher
  190. Sun W, Wang Y, East J, Kimball A, Tkaczuk K, Kesmodel S, et al. Invariant natural killer T cells generated from human adult hematopoietic stem-progenitor cells are poly-functional. Cytokine. 2015;72:48-57 pubmed publisher
  191. Bürgler S, Gimeno A, Parente Ribes A, Wang D, Os A, Devereux S, et al. Chronic lymphocytic leukemia cells express CD38 in response to Th1 cell-derived IFN-γ by a T-bet-dependent mechanism. J Immunol. 2015;194:827-35 pubmed publisher
  192. Weihrauch M, Richly H, von Bergwelt Baildon M, Becker H, Schmidt M, Hacker U, et al. Phase I clinical study of the toll-like receptor 9 agonist MGN1703 in patients with metastatic solid tumours. Eur J Cancer. 2015;51:146-56 pubmed publisher
  193. Van Eyck L, Hershfield M, Pombal D, Kelly S, Ganson N, Moens L, et al. Hematopoietic stem cell transplantation rescues the immunologic phenotype and prevents vasculopathy in patients with adenosine deaminase 2 deficiency. J Allergy Clin Immunol. 2015;135:283-7.e5 pubmed publisher
  194. Chovancová J, Bernard T, Stehlíková O, Sálek D, Janíková A, Mayer J, et al. Detection of Minimal Residual Disease in Mantle Cell Lymphoma. Establishment of Novel 8-Color Flow Cytometry Approach. Cytometry B Clin Cytom. 2014;: pubmed publisher
  195. Stacchini A, Pacchioni D, Demurtas A, Aliberti S, Cassenti A, Isolato G, et al. Utilility of flow cytometry as ancillary study to improve the cytologic diagnosis of thyroid lymphomas. Cytometry B Clin Cytom. 2015;88:320-9 pubmed publisher
  196. Kamburova E, Koenen H, van den Hoogen M, Baas M, Joosten I, Hilbrands L. Longitudinal analysis of T and B cell phenotype and function in renal transplant recipients with or without rituximab induction therapy. PLoS ONE. 2014;9:e112658 pubmed publisher
  197. Fernandez C, Amarasena T, Kelleher A, Rossjohn J, McCluskey J, Godfrey D, et al. MAIT cells are depleted early but retain functional cytokine expression in HIV infection. Immunol Cell Biol. 2015;93:177-88 pubmed publisher
  198. Gibbons D, Fleming P, Virasami A, Michel M, Sebire N, Costeloe K, et al. Interleukin-8 (CXCL8) production is a signatory T cell effector function of human newborn infants. Nat Med. 2014;20:1206-10 pubmed publisher
  199. Rasmussen S, Bilgrau A, Schmitz A, Falgreen S, Bergkvist K, Tramm A, et al. Stable Phenotype Of B-Cell Subsets Following Cryopreservation and Thawing of Normal Human Lymphocytes Stored in a Tissue Biobank. Cytometry B Clin Cytom. 2014;: pubmed publisher
  200. Yu J, Zuo Z, Zhang W, Yang Q, Zhang Y, Tang Y, et al. Identification of immunophenotypic subtypes with different prognoses in extranodal natural killer/T-cell lymphoma, nasal type. Hum Pathol. 2014;45:2255-62 pubmed publisher
  201. Toapanta F, Simon J, Barry E, Pasetti M, Levine M, Kotloff K, et al. Gut-Homing Conventional Plasmablasts and CD27(-) Plasmablasts Elicited after a Short Time of Exposure to an Oral Live-Attenuated Shigella Vaccine Candidate in Humans. Front Immunol. 2014;5:374 pubmed publisher
  202. Li Z, Li W, Li N, Jiao Y, Chen D, Cui L, et al. γδ T cells are involved in acute HIV infection and associated with AIDS progression. PLoS ONE. 2014;9:e106064 pubmed publisher
  203. Della Torre E, Feeney E, Deshpande V, Mattoo H, Mahajan V, Kulikova M, et al. B-cell depletion attenuates serological biomarkers of fibrosis and myofibroblast activation in IgG4-related disease. Ann Rheum Dis. 2015;74:2236-43 pubmed publisher
  204. Li G, Cheng M, Nunoya J, Cheng L, Guo H, Yu H, et al. Plasmacytoid dendritic cells suppress HIV-1 replication but contribute to HIV-1 induced immunopathogenesis in humanized mice. PLoS Pathog. 2014;10:e1004291 pubmed publisher
  205. Chiu Y, Lin I, Su S, Wang K, Yang S, Tsai D, et al. Transcription factor ABF-1 suppresses plasma cell differentiation but facilitates memory B cell formation. J Immunol. 2014;193:2207-17 pubmed publisher
  206. Kusner L, Ciesielski M, Marx A, Kaminski H, Fenstermaker R. Survivin as a potential mediator to support autoreactive cell survival in myasthenia gravis: a human and animal model study. PLoS ONE. 2014;9:e102231 pubmed publisher
  207. Lee Chang C, Bodogai M, Moritoh K, Olkhanud P, Chan A, Croft M, et al. Accumulation of 4-1BBL+ B cells in the elderly induces the generation of granzyme-B+ CD8+ T cells with potential antitumor activity. Blood. 2014;124:1450-9 pubmed publisher
  208. Wilson E, Singh A, Hullsiek K, Gibson D, Henry W, Lichtenstein K, et al. Monocyte-activation phenotypes are associated with biomarkers of inflammation and coagulation in chronic HIV infection. J Infect Dis. 2014;210:1396-406 pubmed publisher
  209. Barbosa R, Silva S, Silva S, Melo A, Pereira Santos M, Barata J, et al. Reduced BAFF-R and increased TACI expression in common variable immunodeficiency. J Clin Immunol. 2014;34:573-83 pubmed publisher
  210. Hoermann G, Blatt K, Greiner G, Putz E, Berger A, Herrmann H, et al. CD52 is a molecular target in advanced systemic mastocytosis. FASEB J. 2014;28:3540-51 pubmed publisher
  211. Itoua Maïga R, Lemieux J, Roy A, Simard C, Néron S. Flow cytometry assessment of in vitro generated CD138+ human plasma cells. Biomed Res Int. 2014;2014:536482 pubmed publisher
  212. Szánthó E, Bhattoa H, Csobán M, Antal Szalmas P, Ujfalusi A, Kappelmayer J, et al. Serum thymidine kinase activity: analytical performance, age-related reference ranges and validation in chronic lymphocytic leukemia. PLoS ONE. 2014;9:e91647 pubmed publisher
  213. Magri G, Miyajima M, Bascones S, Mortha A, Puga I, Cassis L, et al. Innate lymphoid cells integrate stromal and immunological signals to enhance antibody production by splenic marginal zone B cells. Nat Immunol. 2014;15:354-364 pubmed publisher
  214. Mueller A, Brieske C, Schinke S, Csernok E, Gross W, Hasselbacher K, et al. Plasma cells within granulomatous inflammation display signs pointing to autoreactivity and destruction in granulomatosis with polyangiitis. Arthritis Res Ther. 2014;16:R55 pubmed publisher
  215. Chang S, Kohrt H, Maecker H. Monitoring the immune competence of cancer patients to predict outcome. Cancer Immunol Immunother. 2014;63:713-9 pubmed publisher
  216. Doi H, Tanoue S, Kaplan D. Peripheral CD27-CD21- B-cells represent an exhausted lymphocyte population in hepatitis C cirrhosis. Clin Immunol. 2014;150:184-91 pubmed publisher
  217. Frigyesi I, Adolfsson J, Ali M, Christophersen M, Johnsson E, Turesson I, et al. Robust isolation of malignant plasma cells in multiple myeloma. Blood. 2014;123:1336-40 pubmed publisher
  218. Martinez Marignac V, Smith S, Toban N, Bazile M, Aloyz R. Resistance to Dasatinib in primary chronic lymphocytic leukemia lymphocytes involves AMPK-mediated energetic re-programming. Oncotarget. 2013;4:2550-66 pubmed
  219. Elias S, Choudhary P, de Cassan S, Biswas S, Collins K, Halstead F, et al. Analysis of human B-cell responses following ChAd63-MVA MSP1 and AMA1 immunization and controlled malaria infection. Immunology. 2014;141:628-44 pubmed publisher
  220. Lighaam L, Vermeulen E, Bleker T, Meijlink K, Aalberse R, Barnes E, et al. Phenotypic differences between IgG4+ and IgG1+ B cells point to distinct regulation of the IgG4 response. J Allergy Clin Immunol. 2014;133:267-70.e1-6 pubmed publisher
  221. Tan A, Hoang L, Chin D, Rasmussen E, Lopatin U, Hart S, et al. Reduction of HBV replication prolongs the early immunological response to IFN? therapy. J Hepatol. 2014;60:54-61 pubmed publisher
  222. Stacchini A, Aliberti S, Pacchioni D, Demurtas A, Isolato G, Gazzera C, et al. Flow cytometry significantly improves the diagnostic value of fine needle aspiration cytology of lymphoproliferative lesions of salivary glands. Cytopathology. 2014;25:231-40 pubmed publisher
  223. Nichele I, Zamo A, Bertolaso A, Bifari F, Tinelli M, Franchini M, et al. VR09 cell line: an EBV-positive lymphoblastoid cell line with in vivo characteristics of diffuse large B cell lymphoma of activated B-cell type. PLoS ONE. 2012;7:e52811 pubmed publisher
  224. Manjarrez Orduno N, Marasco E, Chung S, Katz M, Kiridly J, Simpfendorfer K, et al. CSK regulatory polymorphism is associated with systemic lupus erythematosus and influences B-cell signaling and activation. Nat Genet. 2012;44:1227-30 pubmed publisher
  225. Zuo Z, Tang Y, Bi C, Zhang W, Zhao S, Wang X, et al. Extraosseous (extramedullary) plasmacytomas: a clinicopathologic and immunophenotypic study of 32 Chinese cases. Diagn Pathol. 2011;6:123 pubmed publisher
  226. Doulatov S, Notta F, Rice K, Howell L, Zelent A, Licht J, et al. PLZF is a regulator of homeostatic and cytokine-induced myeloid development. Genes Dev. 2009;23:2076-87 pubmed publisher
  227. Park C, Majeti R, Weissman I. In vivo evaluation of human hematopoiesis through xenotransplantation of purified hematopoietic stem cells from umbilical cord blood. Nat Protoc. 2008;3:1932-40 pubmed publisher
  228. Jacobi A, Reiter K, Mackay M, Aranow C, Hiepe F, Radbruch A, et al. Activated memory B cell subsets correlate with disease activity in systemic lupus erythematosus: delineation by expression of CD27, IgD, and CD95. Arthritis Rheum. 2008;58:1762-73 pubmed publisher
  229. Friedrichs B, Siegel S, Kloess M, Barsoum A, Coggin J, Rohrer J, et al. Humoral immune responses against the immature laminin receptor protein show prognostic significance in patients with chronic lymphocytic leukemia. J Immunol. 2008;180:6374-84 pubmed
  230. Diaz Blanco E, Bruns I, Neumann F, Fischer J, Graef T, Rosskopf M, et al. Molecular signature of CD34(+) hematopoietic stem and progenitor cells of patients with CML in chronic phase. Leukemia. 2007;21:494-504 pubmed
  231. Kolar G, Mehta D, Pelayo R, Capra J. A novel human B cell subpopulation representing the initial germinal center population to express AID. Blood. 2007;109:2545-52 pubmed
  232. Kolar G, Mehta D, Wilson P, Capra J. Diversity of the Ig repertoire is maintained with age in spite of reduced germinal centre cells in human tonsil lymphoid tissue. Scand J Immunol. 2006;64:314-24 pubmed
  233. Biedermann B, Gil D, Bowen D, Crocker P. Analysis of the CD33-related siglec family reveals that Siglec-9 is an endocytic receptor expressed on subsets of acute myeloid leukemia cells and absent from normal hematopoietic progenitors. Leuk Res. 2007;31:211-20 pubmed
  234. Jamieson C, Gotlib J, Durocher J, Chao M, Mariappan M, Lay M, et al. The JAK2 V617F mutation occurs in hematopoietic stem cells in polycythemia vera and predisposes toward erythroid differentiation. Proc Natl Acad Sci U S A. 2006;103:6224-9 pubmed
  235. Timeus F, Crescenzio N, Sanavio F, Fazio L, Doria A, Foglia L, et al. Multilineage engraftment of refrozen cord blood hematopoietic progenitors in NOD/SCID mice. Haematologica. 2006;91:369-72 pubmed
  236. Ninos J, Jefferies L, Cogle C, Kerr W. The thrombopoietin receptor, c-Mpl, is a selective surface marker for human hematopoietic stem cells. J Transl Med. 2006;4:9 pubmed
  237. Crough T, Burrows J, Fazou C, Walker S, Davenport M, Khanna R. Contemporaneous fluctuations in T cell responses to persistent herpes virus infections. Eur J Immunol. 2005;35:139-49 pubmed
  238. Mateo G, Corral M, Almeida J, López Berges C, Nieto m, García Marcos A, et al. Immunophenotypic analysis of peripheral blood stem cell harvests from patients with multiple myeloma. Haematologica. 2003;88:1013-21 pubmed
  239. Ku C, Padilla J, Grose C, Butcher E, Arvin A. Tropism of varicella-zoster virus for human tonsillar CD4(+) T lymphocytes that express activation, memory, and skin homing markers. J Virol. 2002;76:11425-33 pubmed
  240. Rutella S, Pierelli L, Bonanno G, Sica S, Ameglio F, Capoluongo E, et al. Role for granulocyte colony-stimulating factor in the generation of human T regulatory type 1 cells. Blood. 2002;100:2562-71 pubmed
  241. Manz M, Miyamoto T, Akashi K, Weissman I. Prospective isolation of human clonogenic common myeloid progenitors. Proc Natl Acad Sci U S A. 2002;99:11872-7 pubmed
  242. Lewandowski D, Linassier C, Iochmann S, Degenne M, Domenech J, Colombat P, et al. Phosphatidylinositol 3-kinases are involved in the all-trans retinoic acid-induced upregulation of CD38 antigen on human haematopoietic cells. Br J Haematol. 2002;118:535-44 pubmed
  243. Zhang X, Dormady S, Basch R. Identification of four human cDNAs that are differentially expressed by early hematopoietic progenitors. Exp Hematol. 2000;28:1286-96 pubmed
  244. Barquinero J, Segovia J, Ramirez M, Limon A, Guenechea G, Puig T, et al. Efficient transduction of human hematopoietic repopulating cells generating stable engraftment of transgene-expressing cells in NOD/SCID mice. Blood. 2000;95:3085-93 pubmed
  245. Basch R, Zhang X, Dolzhanskiy A, Karpatkin S. Expression of CD41 and c-mpl does not indicate commitment to the megakaryocyte lineage during haemopoietic development. Br J Haematol. 1999;105:1044-54 pubmed
  246. Grammer A, McFarland R, Heaney J, Darnell B, Lipsky P. Expression, regulation, and function of B cell-expressed CD154 in germinal centers. J Immunol. 1999;163:4150-9 pubmed
  247. Denning Kendall P, Horsley H, Donaldson C, Bradley B, Hows J. Different behaviour of fresh and cultured CD34+ cells during immunomagnetic separation. Br J Haematol. 1999;105:780-5 pubmed
  248. Luque R, Brieva J, Moreno A, Manzanal A, Escribano L, Villarrubia J, et al. Normal and clonal B lineage cells can be distinguished by their differential expression of B cell antigens and adhesion molecules in peripheral blood from multiple myeloma (MM) patients--diagnostic and clinical implications. Clin Exp Immunol. 1998;112:410-8 pubmed
  249. Hryhorenko E, Rittenhouse Diakun K, Harvey N, Morgan J, Stewart C, Oseroff A. Characterization of endogenous protoporphyrin IX induced by delta-aminolevulinic acid in resting and activated peripheral blood lymphocytes by four-color flow cytometry. Photochem Photobiol. 1998;67:565-72 pubmed
  250. Denning Kendall P, Nicol A, Horsley H, Donaldson C, Bradley B, Hows J. Is in vitro expansion of human cord blood cells clinically relevant?. Bone Marrow Transplant. 1998;21:225-32 pubmed
  251. van der Voort R, Taher T, Keehnen R, Smit L, Groenink M, Pals S. Paracrine regulation of germinal center B cell adhesion through the c-met-hepatocyte growth factor/scatter factor pathway. J Exp Med. 1997;185:2121-31 pubmed
  252. Muench M, Roncarolo M, Menon S, Xu Y, Kastelein R, Zurawski S, et al. FLK-2/FLT-3 ligand regulates the growth of early myeloid progenitors isolated from human fetal liver. Blood. 1995;85:963-72 pubmed